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Intact white matter is critical for normal cognitive function.  In traumatic brain injury 
(TBI), chronic cerebral hypoperfusion and Alzheimer’s disease (AD) damage to 
white matter is associated with cognitive impairment.  However, these conditions are 
associated with grey matter damage or with other pathological states and the 
contribution of white matter damage in isolation to their pathogenesis is not known.  
Furthermore, TBI is a risk factor for AD and cerebral hypoperfusion is an early 
feature of AD.  It is hypothesised that white matter damage following TBI or chronic 
cerebral hypoperfusion will be associated with cognitive deficits and that white 
matter changes after injury contribute to AD pathogenesis.  To investigate this, this 
thesis examined the contribution of white matter damage to cognitive deficits after 
TBI and chronic cerebral hypoperfusion and furthermore, investigated the role of 
white matter damage in the relationship between TBI and AD.  Three studies 
addressed these aims.  In the first, mild TBI was induced in wild-type mice and the 
effects on axons, myelin and neuronal cell bodies examined at time points from 4 
hours to 6 weeks after injury.  Spatial reference learning and memory was tested at 3 
and 6 weeks after injury.  Injured mice showed axonal damage in the cingulum, close 
to the injury site in the hours after injury and at 6 weeks, damage in the thalamus and 
external capsule were apparent.  Injured and sham animals had comparable levels of 
neuronal damage and no change was observed in myelin.  Injured animals showed 
impaired spatial reference learning at 3 weeks after injury, demonstrating that 
selective axonal damage is sufficient to impair cognition.  In the second study mild 
 
 vii 
TBI was induced in a transgenic mouse model of AD and the effects on white matter 
pathology and AD-related proteins examined 24 hours after injury.  There was a 
significant increase in axonal damage in the cingulum and external capsule and 
parallel accumulations of amyloid were observed in these regions.  There were no 
changes in tau or in overall levels of AD-related proteins.  This suggests that axonal 
damage may have a role in mediating the link between TBI and AD.  The third study 
used a model of chronic cerebral hypoperfusion in wild type mice and investigated 
white matter changes after one and two months of hypoperfusion as well as a 
comprehensive assessment of learning and memory.  Chronic cerebral hypoperfusion 
resulted in diffuse myelin damage in the absence of ischaemic neuronal damage at 
both 1 and 2 months after induction of hypoperfusion.  Hypoperfused animals also 
showed minimal axonal damage and microglial activation.  Cognitive testing 
revealed a selective impairment in spatial working memory but not spatial reference 
or episodic memory in hypoperfused animals, showing that modest reductions in 
blood flow have effects on white matter sufficient to cause cognitive impairment.  
These results demonstrate that selective damage to white matter components can 
have a long-term impact on cognitive function as well as on the development of AD.  
This suggests that minimisation of axonal damage after TBI is a target for reducing 
subsequent risk of AD and that repair or prevention of white matter damage is a 
promising strategy for rescuing cognitive function in individuals who have 
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1.1 White matter 
 
Alterations in white matter are implicated in the development of cognitive deficits in 
pathological states.  The role of white matter in maintaining communication between 
brain regions underlies its importance in normal cognitive function.  Damage to any 
or all of the multiple components that comprise white matter may disrupt 
communication between grey matter regions, resulting ultimately in impairments in 
cognition and behaviour.  Throughout this thesis the role of white matter changes in 
response to insult and their effect on cognition will be a recurring theme. 
 
1.1.1 Components of white matter 
 
White matter comprises myelinated axons and glial cells, including astrocytes, 
microglia and the oligodendrocytes which produce the myelin sheath and blood 
vessels (Figure 1.1).  Myelination of axons allows for rapid propagation of action 
potentials along the axons’ length by means of saltatory conduction.  The multiple 
layers of myelin enclosing sections of axons are formed in the central nervous system 
by oligodendrocyte processes wrapping around the axon (Bunge et al., 1961).  Not 
only do these layers of myelin increase the efficiency of signal conduction along 





Figure 1.1: Components of white matter 
White matter is comprised of axons, their myelin sheaths, glial cells and 
capillaries.  The myelin sheath is formed by oligodendrocyte processes which 
wrap around the axon multiple times.  Each oligodendrocyte can form 
multiple segments of myelin.  Astrocytes have points of contact with 
oligodendrocytes, axons and the blood brain barrier and may aid in transfer 
of metabolites to and from axons and oligodendrocytes as well as the 




activated microglia under inflammatory conditions and may also provide metabolic 
support (Nave, 2010).  Astrocytes provide trophic support for oligodendrocytes, by 
linking oligodendrocytes to capillaries (Paspalas and Papadopoulos, 1998) as well as 
stimulating the formation of the myelin sheath (Franklin and ffrench-Constant, 
2008).  Myelin sheath formation is a prolonged process, continuing in some regions 
to the sixth decade of life (Benes et al., 1994) and generally proceeding from the 
most caudal to the most rostral regions of the brain (Baumann and Pham-Dinh, 
2001). 
 
1.1.2 Role of white matter in cognition 
 
White matter structure has been observed to vary in conjunction with variations in 
normal cognitive abilities (Fields, 2008; Schmithorst et al., 2005).  However the 
importance of white matter in cognition is perhaps most obvious in instances where 
changes in cognitive performance are associated with damage to white matter.  For 
instance, in both Alzheimer’s disease (AD) and vascular dementia deficits in 
cognitive ability have been demonstrated to correlate with lesions of white matter 
(Gootjes et al., 2004) and even in normal aging decreases in cognitive ability are 
associated with disruption of white matter tracts (O'Sullivan et al., 2001).  Disruption 
of white matter tracts may affect cognition by outright disconnection of regions 
crucial for normal function (e.g. Salat et al., 2010) although the complete severance 
of connections to or from a particular region is an extreme example.  In less severe 
cases, changes in signal conduction velocity due to myelin disruption or interruption 
of conduction along individual axons due to damage can disturb the synchronous 
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firing necessary for the successful function of networks of regions involved in 
cognitive processes (Fell et al., 2001). 
 
1.2 Traumatic brain injury 
 
1.2.1 Traumatic brain injury 
 
Approximately 1 million people present each year at U.K. accident and emergency 
departments with a traumatic brain injury (TBI) (Headway, 2010).  It is the most 
common cause of death and disability in the under 45 age group and can lead to 
persistent long-term cognitive impairment (Bruns and Hauser, 2003; Masel and 
Dewitt, 2010).  Typically, Glasgow Coma Scale (Teasdale and Jennett, 1974) score 
is used to categorise injuries as mild, moderate and severe; with a score of 13 to 15 
being considered mild, 9 to 12 moderate and less than 9 defined as severe (Bruns and 
Hauser, 2003).  The score is determined by measuring patients’ motor 
responsiveness, verbal performance and eye opening (Teasdale and Jennett, 1974).  
Mild injury is estimated to account for 80% of all TBI (Bruns and Hauser, 2003). 
 
Injury mechanisms in TBI fall into primary and secondary categories.  Primary 
mechanisms of injury are those due to direct mechanical trauma and can be further 
subdivided into focal and diffuse injuries (Figure 1.2).  Focal injuries involve local 
damage to specific regions of the brain due to causes such as contusions and 
lacerations following an impact.  Diffuse injuries appear throughout the brain and are 
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not necessarily associated with an injury site and include diffuse axonal injury.  
Secondary damage has a delayed onset and occurs as a consequence of primary 
injury and induces excitotoxicity, oxidative stress, activation of inflammatory 
signalling, brain swelling and increased intracranial pressure and alterations in 
cerebral blood flow and metabolism leading to cell death by necrosis or apoptosis, or 
to damage to axons and exacerbation of primary injuries (Werner and Engelhard, 
2007). 
 
Large, primary focal lesions are frequently observed in moderate to severe injuries 
and involve extensive tissue damage and cell death in addition to diffuse injury 
(Maas et al., 2008).  In cases of moderate to severe injury focal damage may be the 
most clinically significant pathology immediately after injury, unlike mild TBI, 
where diffuse injury, particularly to axons, may have a more important role (Sterr et 
al., 2006).  Secondary damage after injury arises from a number of causes.  These 
include the deleterious effects of some pro-inflammatory cytokines following injury 
(Morganti-Kossmann et al., 2007) and excessive release of glutamate following 
injury, leading to excitotoxic intracellular influx of Ca
2+
 and subsequent damage to 
the neuronal cytoskeleton and membrane (Gennarelli, 1997).  Cerebral blood flow 
may also be altered following injury, resulting in both hyper- and hypoperfusion 
(Martin et al., 1997). 
 
This thesis will focus primarily on mild TBI, where evidence suggests that the long-
term persistence of cognitive symptoms after injury is related to diffuse damage to 





Figure 1.2: Mechanisms and types of injury in traumatic brain injury 
In TBI damage results from primary, mechanical causes which are an 
immediate result of the injury event as well as from secondary, delayed onset 
mechanisms initiated by primary injury events.  Primary injury can be further 
subdivided into focal and diffuse injury types.  Focal injuries have a restricted 
location, close to the site of the initial injury event, while diffuse injuries occur  
in locations remote from the injury site. 
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mild TBI combined with its low mortality rate (af Geijerstam and Britton, 2003) and 
sustained cognitive deficits after injury means that a substantial number of people 
live with a chronic impairment as the result of an apparently minor injury 
(Arciniegas et al., 2005). 
 
1.2.2 White matter damage in mild traumatic brain injury 
 
Mild TBI may not always produce damage that is easily visualised by magnetic 
resonance imaging (MRI) or computed tomography (CT) scans as are normally used 
to identify structural changes after TBI (Inglese et al., 2005; Kraus et al., 2007) and 
the high survival rates for this level of injury mean that opportunities for studying the 
pathological consequences of mild TBI post-mortem are limited.  The development 
of diffusion tensor imaging (DTI) MRI technique for imaging white matter (Basser, 
1994) has proven useful in studying white matter changes after mild TBI.  Changes 
in indices of white matter integrity are typically observed in a variety of regions and 
at time points ranging from days to years after injury (Inglese et al., 2005; Kraus et 
al., 2007; Messé et al., In press).  Changes in white matter integrity also coexist with 
long-term deficits in short-term and working memory as well as attention (Kraus et 
al., 2007).  Imaging studies are, however, limited by the difficulty in identifying 
which components of white matter are affected in mild TBI, meaning they are 




1.2.3 Cerebral hypoperfusion after traumatic brain injury 
 
Cerebral hypoperfusion or a reduction in cerebral blood flow (CBF) is frequently 
observed secondary injury following TBI and is predictive of poor recovery 
following TBI (Overgaard and Tweed, 1983).  A number of mechanisms can give 
rise to cerebral hypoperfusion: damage to cerebral blood vessels due to shearing 
forces during injury, failure of cerebrovascular autoregulation, alterations in levels of 
cholinergic neurotransmitters and increased vasoconstriction due to prostaglandins 
(Werner and Engelhard, 2007).  Cerebral hypoperfusion also reduces the amount of 
oxygen and glucose being delivered to cells and results in cell death due to failures in 
ATP production followed by disruptions in ionic homeostasis and subsequent 
excitotoxicity.  This is in addition to excitotoxic events caused by TBI itself, 
exacerbates the damage caused by this mechanism.  Other secondary injuries that can 
be induced by severe hypoperfusion as well as by TBI include generation of reactive 
oxidative species and inflammation (Bramlett and Dietrich, 2004).  As well as 
inducing reductions in CBF, excitotoxicity following TBI can cause increased 
metabolic demand in injured tissue which can increase the vulnerability of cells to 
ischaemic insult, meaning that ischaemic tissue damage may occur with smaller 
reductions in blood flow than in otherwise healthy tissue (Bramlett and Dietrich, 
2004).  Cerebral hypoperfusion may also have a role in long-term impairment after 
mild TBI, as suggested by reports of hypoperfusion in the frontal, pre-frontal, 
temporal cortices and sub-cortical structures detected 2 years after mild TBI in a 
group of patients with persistent cognitive deficits (Bonne, 2003).  Reduced CBF has 
been observed in the hours following lateral FPI in rats (Yamakami and McIntosh, 
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1989;1991).  Regional reductions in CBF have been found to persist up to 9 months 
after lateral FPI (Hayward et al., In press). 
 
1.2.4 Models of traumatic brain injury 
 
Given the diversity of injury types in human TBI it is not surprising that there are a 
number of rodent models of TBI.  Frequently used models include weight drop, 
controlled cortical impact (CCI) and fluid percussion injury (FPI) (Cernak, 2005; 
Morales et al., 2005 for review).  In the CCI model the injury is produced by the 
impact of a pneumatic cylinder on the exposed, intact dura (Dixon et al., 1991; Smith 
et al., 1995).  Progressive cell loss in the cortex, hippocampus and thalamus has been 
reported, along with damage to the afferent connections from these regions.  This 
makes this technique suitable for modelling injury types with focal mechanical 
trauma to the brain.  In the weight drop model a guided weight is dropped on to 
either the exposed skull or dura of the animal (Feeney et al., 1981; Tang et al., 
1997a;b).  A modified version of this technique called the impact acceleration model 
involves attachment of a metal plate to the skull to avoid skull fracture.  There is the 
risk of a second, uncontrolled injury if the weight bounces on the skull after being 
dropped.  Focal damage to the injury site can be modelled using this technique at 
severe injury levels (Feeney et al., 1981) and lower impact levels are capable of 
producing cell loss and diffuse axonal damage (Lewen et al., 1995; Tang et al., 
1997b), while the impact acceleration version is useful for inducing selective diffuse 
axonal injury.  In models of mild TBI, weight drop injury has been demonstrated to 
produce a learning deficit that persists to 90 days after injury in the absence of 
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structural changes visible using MRI (Zohar et al., 2003).  Other studies modelling 
mild TBI have demonstrated learning and memory impairments up to 3 weeks after 
injury in conjunction with cortical and hippocampal cell loss (Tang et al., 1997a) but 
there has been a lack of investigation of white matter pathology following mild TBI 
in conjunction with behavioural assessment. 
 
In FPI a fluid pulse applied to the intact dura through an opening in the skull 
produces the injury (McIntosh et al., 1989).  There are two varieties of FPI which are 
distinguished by the location of the injury site.  In midline FPI the injury site is 
located over the midline, whereas in the lateral model it is placed lateral to the 
midline between bregma and lambda.  This difference in injury position results in 
less brainstem involvement and lower mortality rates than in the midline version of 
the model, making it more suitable for modelling mild injuries (McIntosh et al., 
1989).  Increased focal cortical cell loss after lateral FPI is associated with increasing 
injury severity and has been observed to progress up to 1 year after severe injury in 
conjunction with diffuse hippocampal and thalamic cell loss (Pierce et al., 1998).  
Diffuse axonal degeneration continuing after injury also occurs in a range of regions 
including the brainstem, caudate/putamen, corpus callosum and external capsule up 
to 35 days after injury in mice (Carbonell and Grady, 1999) and 1 year in rats (Pierce 
et al., 1998).  Lateral FPI also results in deficits in working memory, spatial learning 
and spatial memory, measured at time points from 2 days to 1 year after injury and is 
associated with cell loss in the cortex, hippocampus and thalamus as well as diffuse 




Rats and mice are the species most commonly used to model TBI but the 
lissencephalic brain structure of rodents, combined with the relatively small mass of 
the rodent brain means that there are significant mechanical differences between TBI 
in rodents and humans (Morales et al., 2005).  Primates, cats and pigs have 
gyrencephalic brains and have been used to model TBI.  In cats, FPI has been shown 
to produce axonal damage, detectable between 1 and 6 hours after injury (Erb and 
Povlishock, 1988) as well as damage to neurons in hindbrain regions (Sullivan et al., 
1976).  In miniature pigs and primates rotational forces induced by acceleration of 
the head produce diffuse white matter damage (Gennarelli et al., 1982; Ross et al., 
1994; Smith et al., 1997) as well as neuronal damage in the hippocampus (Smith et 
al., 1999; Smith et al., 1997). 
 
1.3 Chronic cerebral hypoperfusion 
 
1.3.1 Chronic cerebral hypoperfusion 
 
Modest long-term reductions in blood flow are linked to white matter pathology 
(Pantoni and Garcia, 1997).  CBF decreases with age (Stoquart-ElSankari et al., 
2007) while white matter damage is also observed with greater frequency with 
advancing age (de Leeuw et al., 2001).  In addition, chronic hypoperfusion and 
linked white matter damage are associated with impaired cognitive function in aging 
(Appelman et al., 2010) and reductions in CBF correlate with cognitive impairment 
(Tiehuis et al., 2008).  The mechanism of the link between chronic hypoperfusion 
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and white matter damage is not clear as minor reductions in CBF, such as the 20 to 
25% decrease observed in aging, are not sufficient to cause cell death (Stoquart-
ElSankari et al., 2007).  Examination of the effects of these relatively modest 
reductions in CBF is complicated in aging humans by the fact that they are caused by 
a diversity of pathological states such as hyper- and hypotension, atherosclerosis, and 
diabetes.  This renders development of animal models of pure chronic hypoperfusion 
necessary for establishing the impact of chronically reduced CBF on white matter 
and cognition. 
 
1.3.2 Models of chronic cerebral hypoperfusion 
 
Modelling chronic hypoperfusion in animals allows isolation of its pathological and 
cognitive effects.  The most frequently used model of chronic cerebral hypoperfusion 
is bilateral occlusion of the common carotid arteries in the rat.  This model shows 
neuronal damage, notably in the hippocampus and widespread damage to white 
matter, both of which increase with increasing duration of hypoperfusion (Ohtaki et 
al., 2006; Wakita et al., 2002).  The white matter damage observed is characterised 
by loss of myelination and rarefaction and vacuolisation of the corpus callosum and 
the optic tract, which appears to be particularly vulnerable in this model (Farkas et 
al., 2004a; Wakita et al., 2002).  A variety of cognitive deficits have also been 
observed in this model, including spatial and nonspatial learning impairments, 
working memory deficits and increased anxiety (de Bortoli et al., 2005; Farkas et al., 
2004b; Murakami et al., 2000).  These deficits have been observed to worsen over 
time following the induction of hypoperfusion (Liu et al., 2005; Sopala and Danysz, 
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2001).  However, interpretation of behavioural results in this model is complicated 
by preferential damage to the optic tract as well as the presence of other visual 
system defects, a major confound in the use of behavioural tasks which are heavily 
reliant on intact vision, such as the Morris water maze and the radial arm maze. 
 
In gerbils, where complete occlusion of the common carotid arteries results in a more 
severe pathology than in the rat, owing to vascular differences between the species 
(Mayevsky and Breuer, 1992), stenosis of the common carotid arteries produces 
damage to white matter and a deficit in learning (Kurumatani et al., 1998).  Stenosis 
is achieved by placing wire coils of a specified diameter around the arteries.  
Adaptation of this technique to the mouse has resulted in a model with diffuse white 
matter lesions appearing 14 days after the induction of hypoperfusion and persisting 
at 30 days (Shibata et al., 2004).  Assessment of behavioural abilities revealed a 
deficit in working memory while spatial reference learning, associative learning and 
levels of locomotor activity remained normal (Shibata et al., 2007).  Damage in this 
model is selectively to white matter and damage in the optic tract is not reported to 
be higher than in other regions, meaning that the observed behavioural changes are 
most likely due to diffuse damage to white matter.  There are a number of elements 
of this model that require further investigation, including parallel assessment of 
behaviour and pathology in the same animals and determination of whether chronic 




1.4 Alzheimer’s disease 
 
1.4.1 Alzheimer’s disease pathology 
 
AD is a common neurodegenerative disorder that results in profound cognitive 
disability.  The disease is defined by progressive cognitive impairment and by the 
post-mortem detection of insoluble extracellular plaques containing aggregated 
amyloid β (Aβ) protein and intracellular fibrillar aggregations of 
hyperphosphorylated tau protein.  Areas particularly affected include the cortex, 
hippocampus, entorhinal cortex and amygdala (Wenk, 2003).  AD is estimated to 
affect 35 million people worldwide and incurs considerable healthcare costs and 
places a large burden on those who care for sufferers (Alzheimer's Disease 
International, 2010; Querfurth and LaFerla, 2010).  There are a variety of risk factors 
for AD, including apolipoprotein E4 genotype (Corder et al., 1993), TBI (Heyman et 
al., 1984) and vascular factors including stroke, hypertension and cerebrovascular 
disease (Qiu et al., 2007 for review).  The majority of cases occur in people aged 
over 65 and have no known cause, the rest (~1%) are due to heritable mutations in 
genes encoding either the amyloid precursor protein (APP); from which Aβ is 
derived or the presenilins; elements of the APP cleaving enzyme γ – secretase.  The 
identification of these heritable mutations affecting Aβ production that lead to AD, in 
the absence of tau mutations which lead to AD, lead to the amyloid cascade 
hypothesis (Hardy and Higgins, 1992) which gives primacy to the role of Aβ in AD 
pathogenesis.  This hypothesis states that Aβ deposition is the causal factor in AD 
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and that other pathological characteristics of AD; neurofibrillary tangles, cell loss 
and cognitive impairment result directly from this deposition.  Although some 
questions have been answered as to the processes involved in the generation of Aβ, 
how it may interact with tau to produce hyperphosphorylated aggregates and how 
both these proteins exert their neurotoxic effects, it is not known what precipitates 
these events.  The amyloid cascade hypothesis has proven useful for framing 
questions about the progression of AD pathology but does not make predictions 
regarding initiating factors.  Recently, Hardy (2009) has updated the hypothesis to 
incorporate a vascular element to the development of AD; this updated hypothesis 
posits that vascular damage may be caused by Aβ deposition while also initiating Aβ 
damage. 
 
Aβ is formed by sequential cleavage of APP by β – and γ – secretases (Figure 1.3).  
APP is a transmembrane protein of unknown normal function although it is thought 
to be involved in axonal transport, cell adhesion, cholesterol metabolism and gene 
transcription (Turner et al., 2003).  Cleavage of APP by β – secretase in the 
extracellular domain produces a 99 residue C-terminal fragment that is cleaved in the 
transmembrane domain by the protein complex γ – secretase to form the Aβ peptide, 
which is 36 to 43 amino acids in length.  Alternatively cleavage by α – secretase 
occurs within the Aβ domain of APP and precludes the formation of Aβ (Goedert 
and Spillantini, 2006).  The principle products of amyloidogenic cleavage are Aβ 
peptides that are 40 or 42 amino acids long (Aβ40 and Aβ42, respectively).  Aβ tends 
to form aggregates of multiple peptides with the solubility and toxicity of these 





Figure 1.3: Amyloidogenic and non-amyloidogenic cleavage of amyloid precursor protein (APP) 
Non-amyloidogenic cleavage of APP is by α – secretase with in the Aβ region of APP in the first instance to produce soluble 
extracellular APP domain α (sAPPα) and an 83 amino acid long C-terminal fragment.  This is then cleaved by γ – secretase to 
produce a P3 fragment and an APP intracellular domain (AICD).  The first step in amyloidogenic cleavage of APP is by β – 
secretase which produces sAPPβ and a 99 amino acid C-terminal fragment that is cleaved by γ – secretase to produce  
Aβ and AICD. 
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aggregation of Aβ results in the formation of protofibrils and then fibrils which are 
deposited extracellularly as insoluble plaques (LaFerla et al., 2007).  Aβ42 is the more 
aggregation prone form of the protein and is more neurotoxic than Aβ40 (Findeis, 
2007).  Soluble oligomers of Aβ show greater levels of neurotoxicity than the 
insoluble plaques of Aβ that are deposited in the brains of AD patients (Finder and 
Glockshuber, 2007).  Levels of soluble Aβ oligomers also correlate with cognitive 
impairment better than either total levels of Aβ or numbers of Aβ plaques, further 
suggesting an important role for these formations of Aβ (Tomic et al., 2009).  The 
mechanism of the neurotoxic effects of Aβ is unclear although it has been shown to 
have a deleterious effect on oxidative phosphorylation (Rhein et al., 2009; Yao et al., 
2009), induce inflammation (Apelt and Schliebs, 2001; Richards et al., 2003) and 
apoptosis (Nelson and Alkon, 2007), impair fast axonal transport (Pigino et al., 2009) 
and alter intracellular calcium homeostasis (Zempel et al., 2010).  There is also 
evidence that toxicity of Aβ may be mediated by tau (Findeis, 2007; Wilcock et al., 
2009; Zempel et al., 2010). 
 
Tau is a microtubule associated protein, involved in stabilisation of the axonal 
cytoskeleton.  The hyperphosphorylation of tau reduces its affinity for microtubules 
and promotes its aggregation into paired helical filaments, which are the main 
component of the neurofibrillary tangles observed in AD (Alonso et al., 1996).  The 
amount of neurofibrillary tangles observed also correlates with the cognitive status of 
AD patients (Goedert and Spillantini, 2006).  Hyperphosphorylated tau is also 
neurotoxic, with a number of hypothesised mechanisms of action including 
sequestration of normal microtubule associated proteins, disruption of microtubule 
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dynamics and disruption of intracellular trafficking (Wang and Liu, 2008).  Aβ and 
tau have been demonstrated to act in a synergistic way to cause defects in oxidative 
phosphorylation (Rhein et al., 2009), suggesting that the progression of pathology in 
AD may not be as linear in fashion as suggested by the amyloid cascade hypothesis.  
Evidence from animal models of AD (see below) shows that the presence of 
pathological forms of tau does not lead to the development of Aβ pathology, while 
tau pathology may be prevented by clearance of Aβ, confirming this prediction of the 
amyloid cascade hypothesis.  How Aβ affects tau phosphorylation status is unknown 
but inflammatory cytokines induced by Aβ are known to affect tau phosphorylation 
(Li et al., 2003).  Aβ also activates tau kinases such as cyclin dependent kinase 5 
(Cdk5) and glycogen synthase kinase 3β (GSK-3β) (Blurton-Jones and LaFerla, 
2006). 
 
1.4.2 White matter in Alzheimer’s disease 
 
In addition to the well characterised Aβ and hyperphosphorylated tau pathology 
changes in white matter are also associated with AD (e.g. Bartzokis et al., 2003; 
Brun and Englund, 1986a; Englund et al., 1988; Yoshita et al., 2006).  White matter 
alterations are an early event in the development of AD (Stokin et al., 2005) and in at 
least one transgenic model precede the development of classic AD plaque and tangle 




Pathological investigation (Brun and Englund, 1986a, b; Englund et al., 1988) has 
shown loss of myelin, axons and oligodendrocytes in post-mortem AD brains as well 
as astrocytic gliosis.  These findings have been confirmed in studies using magnetic 
resonance imaging (MRI) (Bartzokis et al., 2003; Targosz-Gajniak et al., 2009; 
Yoshita et al., 2006) and although the evidence for a direct correlation between 
disease progression and volume of white matter abnormalities observed is mixed it is 
clear that volume of white matter damage is related to age (Bartzokis et al., 2003; 
Targosz-Gajniak et al., 2009).  Individuals with mild cognitive impairment (MCI), a 
high proportion of whom go on to develop AD (Landau et al., 2010) also show white 
matter changes in MRI scans (DeCarli et al., 2001) and these changes may be 
predictive of later conversion to AD (Davatzikos et al., In press).  Also, higher levels 
of white matter damage have been reported in individuals with AD, compared to 
those with MCI, suggesting that there may be a relationship between white matter 
damage and severity of cognitive impairment (Targosz-Gajniak et al., 2009; Wu et 
al., 2002).  As with white matter lesions in normal aging populations, white matter 
changes in AD are also linked to cerebral hypoperfusion (Fernando et al., 2006; 
Meyer et al., 2008; Ruitenberg et al., 2005).  Cerebral hypoperfusion is an early 
event in AD and has been detected in temporal and parietal regions before the onset 
of cognitive decline (Farkas and Luiten, 2001).  In individuals with MCI, 
hypoperfusion, as well as the presence of white matter lesions is detectable prior to 
the development of AD (Farkas and Luiten, 2001; Matsuda et al., 2007). 
 
Bartzokis (2004; 2009) has suggested that myelin damage is a primary pathological 
event in AD where homeostatic responses to age-related loss of vulnerable late-
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myelinating oligodendrocytes are responsible for the classic plaque and tangle 
pathology of AD.  Direct validation of this theory in animal models is required, 
however it is known that oligodendrocytes are vulnerable to Aβ related toxicity 
(Desai et al., 2010; Xu et al., 2001) and that axonal damage can be induced by 
expression of mutant human tau in oligodendrocytes, due to disruption of axonal 
transport (Higuchi et al., 2005).  Alternatively, it has also been proposed that deficits 
in axonal transport may lead to the synaptic and neuronal loss observed in AD and 
also to increased processing of APP to Aβ and increased phosphorylation of tau.  
However, Aβ can also have effects on axonal transport, making it unclear whether it 
is a cause or result of impaired axonal transport (Muresan and Muresan, 2009).  The 
direction of the relationship between AD and white matter damage may not be clear 
but it is evident that white matter pathology is a prominent feature of AD. 
 
1.4.3 Models of Alzheimer’s disease 
 
The discovery of genes responsible for early onset, familial AD has allowed the 
generation of transgenic mouse models of AD.  A variety of mutations in genes 
encoding APP and presenilin 1 and 2 are responsible for the heritable forms of the 
disease in humans.  Mutations in the APP gene can result in increased production of 
total Aβ or an increase in the proportion of the long form of Aβ42 relative to Aβ40 
(Findeis, 2007; Goedert and Spillantini, 2006).  Mutations in either of the presenilin 





Although aging mice do not normally display abnormalities in Aβ or tau like those 
seen in AD (Selkoe, 1991), introduction of mutant versions of human genes into the 
mouse genome results in models recapitulating some of the Aβ-related pathological 
features of AD (McGowan et al., 2006 for review).  Lines transgenic for APP with 
one or more mutations develop amyloid plaques and cognitive deficits in an age-
dependent manner (e.g. Dodart et al., 1999; Games et al., 1995; Mucke et al., 2000).  
For instance, the PDAPP line, characterised by Games (1995) display Aβ plaques 
beginning at 6 to 9 months of age and increasing in density as the animals age.  
Deficits in recognition and episodic memory have been reported from 3 months old 
and progressing to 18 to 21 months of age (Chen et al., 2000; Dodart et al., 1999).  
The timing and location of amyloid pathology is variable between transgenic lines 
due to differences in the promoter under which the transgene is expressed and in 
levels of transgene expression.  Mice expressing mutant presenilin transgenes in 
addition to the mutant APP gene show a similar pattern of pathology and cognitive 
deficits to those transgenic only for APP but with an accelerated rate of development 
(Borchelt et al., 1997; Holcomb et al., 1998).  Expression of mutant presenilin is 
itself sufficient to increase levels of Aβ42 (Duff et al., 1996).  Unlike human AD 
however, neuronal loss is not a feature of these models and tau pathology is also 
absent.  Despite these limitations, transgenic mouse models of AD have allowed 
identification of the importance of oligomeric forms of Aβ in cognitive deterioration 
owing to the presence of a behavioural deficit prior to the onset of amyloid plaque 
pathology (Borchelt et al., 1997; Cleary et al., 2005; Lesné et al., 2006; Westerman 




Modelling of the tau pathology observed in human AD has necessitated the use of 
transgenics expressing genes not related to AD as there are no tau-related mutations 
linked to AD.  Expression of human tau with a mutation causing frontotemporal 
dementia and parkinsonism linked to chromosome 17 in mice leads to development 
of hyperphosphorylated tau throughout the brain, along with massive neuronal 
degeneration and cognitive changes but without changes in Aβ (Lewis et al., 2000).  
As noted by Allen et al. (2002) the formations of hyperphosphorylated tau seen in 
these models do not necessarily correspond to the forms observed in AD.  
Additionally, the presence of extensive motor deficits in these models renders 
attribution of behavioural changes to neuronal loss or the presence of pathology 
difficult (e.g. Lewis et al., 2000; Ramsden et al., 2005).  Similar to findings in 
models of amyloid pathology the link between the classic neurofibrillary tangle 
pathology of AD has not been shown to be clearly linked to cognitive decline in 
these models.  Suppression of mutant tau expression has been found to reverse the 
memory deficits observed and halt neuronal death without halting the increase in 
amount of neurofibrillary tangles (SantaCruz et al., 2005), indicating that 
neurofibrillary tangles are not necessarily neurotoxic themselves but that 
destabilisation of microtubules and impairment of axonal transport may be the basis 
for this (Sun et al., 2008; Zhang et al., 2004). 
 
Recapitulation of both of the characteristic pathological features of AD in a single 
model has led to the development of transgenic lines containing combinations of 
APP, presenilin and tau transgenes.  These models, such as those characterised by 
Oddo et al. (2003a, b) and Lewis et al. (2001) have demonstrated the temporal order 
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of progression of these features of AD with Aβ deposits appearing prior to 
neurofibrillary tangles and acceleration of neurofibrillary tangles appearance relative 
to single transgenics, demonstrating an interaction between Aβ and tau pathology.  
Interestingly accumulation of endogenous mouse tau in mice transgenic for mutant 
human APP has been induced by knockout of NO synthase 2, giving further evidence 
of the role of Aβ in the development of tau pathology even in the absence of non-AD 
relevant tau mutations (Colton et al., 2006; Wilcock et al., 2008; 2009).  These 
models displaying multiple pathologies also exhibit synaptic dysfunction (Oddo et 
al., 2003b) and behavioural changes (Martinez-Coria et al.), similar to transgenic 
lines displaying only Aβ pathology but in the case of the Wilcock et al. (2008) study 
at least, the presence of tau abnormalities exacerbated the behavioural deficits 
observed in single APP transgenics.  Administration of antibodies against Aβ to the 
triple transgenic model developed by the LaFerla group demonstrated that clearance 
of Aβ pathology in this model also led to a reduction in tau pathology (Oddo et al., 
2004), further demonstrating the link between Aβ and tau pathology in AD. 
 
White matter abnormalities are also a feature of transgenic mouse models of AD (e.g. 
Desai et al., 2009; 2010; Wirths et al., 2007).  Reductions in myelination in the 
hippocampus and entorhinal cortex of triple transgenic mice as well as reductions in 
oligodendrocyte markers have been recorded prior to the age at which pathology 
typically begins in these animals (Desai et al., 2009).  This reduced myelination is 
progressive and is associated with abnormalities in axonal morphology at up to 6 
months of age.  Similarly, progressive axonopathy has been observed in the brains of 
APP/PS1 transgenic mice by Wirth et al (2007).  The use of DTI in APP transgenic 
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mice from 8 to 18 months of age suggested the presence of axonal damage after 8 
months of age and myelin damage from 15 months (Song et al., 2004; Sun et al., 
2005).  Cerebral hypoperfusion is another early event in AD that is recapitulated in 
transgenic models, with reduced blood flow having been recorded prior to the 
appearance of Aβ plaques (Niwa et al., 2002). 
 
As has been noted above mutations in the APP and PS1 genes account for only 1% 
of cases of AD in humans, also AD in humans is not associated with mutations in 
genes encoding tau.  This is a factor that places some restrictions on extrapolation of 
findings from transgenic mice into humans, however other species have been 
reported to develop AD-like pathology and cognitive deficits in an age-dependent 
manner.  Primate species, such as the rhesus macaque, develop Aβ plaques with 
aging (Ichinohe et al., 2009; Uno et al., 1996)) although, in contrast to humans, the 
main Aβ species found in plaques is Aβ40 (Sani et al., 2003).  Rhesus macaques also 
display neuronal loss and axonal loss associated with the presence of Aβ plaques 
(Shah et al., 2010).  Deposition of Aβ is also observed in aged dogs and the 
anatomical distribution of Aβ deposition is similar to that observed in humans, with 
the prefrontal and entorhinal cortices showing particularly high levels of Aβ 
deposition (Head et al., 2000) as in humans, the primary form of Aβ deposited is 
Aβ42 (Nakamura et al., 1997).  Intraneuronal aggregations of hyperphosphorylated 
tau are also observed with aging (Pugliese et al., 2006).  Dogs also display cognitive 
deficits associated with Aβ pathology (Head et al., 1998).  Aging cats also show Aβ 
and hyperphosphorylated tau pathology as well as age-related cognitive changes 
(Gunn-Moore et al., 2006; Gunn-Moore et al., 2007).  The long time required for the 
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development of pathology in these species (~9 years in dogs and ~25 years in rhesus 
macaques) has meant that although these models replicate features of human 
sporadic AD their use has been somewhat limited 
 
1.5 Traumatic brain injury and Alzheimer’s disease 
 
1.5.1 Traumatic brain injury as a risk factor for Alzheimer’s disease 
 
Although AD has no known cause a number of risk factors have been identified with 
the chief environmental one being a history of TBI.  Epidemiological studies show 
increased incidence of AD in individuals with a history of TBI (Fleminger et al., 
2003; Graves et al., 1990; Guo et al., 2000; Mortimer et al., 1991; Schofield et al., 
1997), even at intervals up to 50 years after TBI (Plassman et al., 2000).  These 
studies have mainly focused on moderate to severe injuries which are readily 
verifiable owing to the existence of medical records meaning that the picture 
concerning the more common mild TBI is not as clear.  Work carried out in 
populations of athletes, who may experience multiple mild TBIs suggests that mild 
TBI can also have a significant impact on the likelihood of developing cognitive 
impairment in later life (De Beaumont et al., 2009; Guskiewicz et al., 2005; Lipton et 
al., 2008; Matser et al., 1999). 
 
As well as observed increases in the rate of AD observed following TBI AD-type 
pathology has also been noted.  Studies of individuals who have died as a result of 
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TBI have found Aβ plaques to be present regardless of age (Graham et al., 1995; 
Horsburgh et al., 2000; Roberts et al., 1994).  Analysis of tissue removed from the 
brains of severely brain injured patients hours after injury also showed deposited Aβ 
in one third of patients (Ikonomovic et al., 2004).  Plaques composed of the more 
aggregation prone Aβ42 have also been demonstrated to be more frequent than those 
composed of Aβ40 (Horsburgh et al., 2000; Ikonomovic et al., 2004).  However, post-
mortem studies of patients who survived for several days to years after TBI do not 
show persistent Aβ plaque pathology (Chen et al., 2009; Macfarlane et al., 1999).  
TBI-induced microglial activation may be responsible for clearance of Aβ plaques 
(Hickman et al., 2008; Koenigsknecht and Landreth, 2004).  While Aβ plaques have 
not been shown to be a long-term feature of pathology after TBI intra-axonal 
accumulation of Aβ in damaged axons has been demonstrated to persist for up to 3 
years after TBI (Chen et al., 2009).  The cognitive status of these long-term survivors 
of TBI is indeterminate, precluding investigation of links between the presence of 
pathology in the brain and deficits in cognition. 
 
Neurofibrillary tau pathology and Aβ deposition are characteristic of dementia 
pugilistica, a dementia primarily observed in boxers and other athletes who have 
received multiple TBIs (Schmidt et al., 2001; Toth et al., 2005).  Behaviourally, this 
syndrome is defined by cognitive and motor impairments and the composition of the 
neurofibrillary tangles is similar to that observed in AD (Schmidt et al., 2001).  After 
acute head injury however, evidence of increased numbers of neurofibrillary tangles 
was not present although tau immunoreactivity was present (Smith et al., 2003a).  
The absence of neurofibrillary tangle pathology in acute studies may reflect either a 
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necessity for multiple injuries to result in tau pathology as in dementia pugilistica or 
the temporal order of development of AD pathology as demonstrated in transgenic 
models. 
 
1.5.2 Alzheimer’s disease pathology in animal models of traumatic brain injury 
 
While investigation of TBI on the presence of AD-related pathology in humans 
generally shows that TBI produces AD-type changes, particularly in Aβ, the 
evidence from animal studies is more equivocal.  Acute increases in total Aβ levels 
in the brains of mice transgenic for mutant human APP have been observed but not 
linked to an increase in Aβ pathology (Smith et al., 1998).  In fact, reductions in the 
levels of Aβ plaques have been observed following severe injury in similar models 
(Nakagawa et al., 1999; 2000).  In contrast to these studies of severe injury mild TBI 
has been demonstrated to induce increased Aβ at 16 weeks after injury and this 
increase in deposition is accelerated when animals are subjected to multiple mild TBI 
(Uryu et al., 2002).  Importantly, studies in transgenic mice are using animals that 
either already display Aβ plaques or will go on to develop them, owing to their 
genotype.  This means that modelling TBI in this fashion introduces a further insult 
into an already pathological system, something which is unlikely to be the case in 
humans, particularly in young sufferers of TBI. 
 
Work on non-transgenic rats has failed to show extracellular deposition of Aβ in 
response to TBI but it has demonstrated persistent accumulation of Aβ in damaged 
axons, similar to human studies (Iwata et al., 2002) as well as increased levels of Aβ 
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in cells at 6 months after injury (Hoshino et al., 1998).  In pigs extracellular 
deposition of Aβ has been reported in addition to accumulation of Aβ in injured 
axons (Chen et al., 2004; Smith et al., 1999).  These changes were found to persist up 
to 6 months after injury and were in addition to increases in overall levels of Aβ in 
the first 7 days after injury (Chen et al., 2004). 
 
Accumulation of hyperphosphorylated tau following TBI has been less frequently 
investigated in animals.  In mice already displaying hyperphosphorylated tau TBI 
produces a transient increase in tau hyperphosphorylation at 4 hours after injury 
(Genis et al., 2000).  At 9 months after repeated TBI mice transgenic for human tau 
do not show changes in tau phosphorylation (Yoshiyama et al., 2005).  Investigations 
of tau-related changes in other species do not agree with these studies, however.  
Accumulation of tau in damaged axons as well as in neurons has also been observed 
in pigs from 3 to 10 days after injury (Smith et al., 1999) while rats show increases in 
the levels of hyperphosphorylated tau observed in neurons over time up to 6 months 
after injury (Hoshino et al., 1998).  The low number of studies investigating tau 
pathology following TBI in animal models makes generalisations in this area 
difficult, although it does appear that there is some impact of TBI on tau while the 




1.5.3 Potential mechanisms of traumatic brain injury influence on Alzheimer’s 
disease 
 
Pathological studies of the development of Aβ or tau pathology following TBI have 
demonstrated some ways in which TBI can influence the development of AD-type 
pathology.  In particular, co-accumulation of APP, Aβ and proteins necessary for 
production of Aβ from APP in the damaged axons of both pigs and humans after TBI 
(Chen et al., 2004; Uryu et al., 2007) points towards a role for damaged axons as 
localised reservoirs of substrate for secretases to cleave to Aβ.  Accumulation of APP 
in injured axons is likely due to interruptions in anterograde axonal transport caused 
by damage to the neuronal cytoskeleton, a source of tau alterations due to disruption 
of microtubule assembly (Geddes et al., 1999).  In addition to accumulation of 
proteins involved in the generation of Aβ in axons, overall levels of APP have been 
shown to be increased following TBI at time points ranging from hours to days after 
injury (Szczygielski et al., 2005), providing another potential pool of APP from 
which the Aβ pathology observed in grey matter could be derived.  Pro - 
inflammatory cytokines including interleukin-1α (IL-1α), IL-1β, IL-6 and tumour 
necrosis factor-α (TNFα) induced by TBI have also been demonstrated to regulate 
processing of APP to Aβ (Ge and Lahiri, 2002; Goldgaber et al., 1989; Schmitz and 
Chew, 2008) and to influence tau phosphorylation via their effects on tau kinases 






The importance of white matter in cognitive function is highlighted by situations in 
which damage to white matter results in cognitive impairment.  TBI, chronic 
hypoperfusion and AD are all associated with damage to white matter and cognitive 
impairment.  However the contribution of white matter damage in isolation to the 
pathogenesis of each of these conditions is not known.  It is hypothesised that white 
matter damage following TBI or chronic cerebral hypoperfusion will be associated 
with a cognitive deficit and that white matter changes after injury will result in the 
development of AD related pathology.  To investigate this, this thesis will examine 
the effects of TBI and hypoperfusion on white matter and associated cognitive 
deficits as well as examining the role of white matter damage in the relationship 
between TBI and AD. 
 
1.7 Thesis aims and hypotheses 
 
Chapter 3: Effect of mild traumatic brain injury on pathology and cognition in wild-
type mice 
 
It was hypothesised that mild TBI would cause selective damage to axons at short 
and long-term time points after injury as well as inducing a persistent deficit in 




To investigate the impact of mild TBI on white matter damage as well as cognitive 
deficits in mice, a detailed examination of axons, myelin and neuronal cell bodies 
was undertaken at time points ranging from 4 hours to 6 weeks as well as an 
investigation of learning and memory 3 and 6 weeks after injury. 
 
Chapter 4: Effect of mild traumatic brain injury on white matter and Alzheimer’s 
disease pathology in an Alzheimer’s disease model 
 
In a transgenic model of AD it was hypothesised that mild TBI would cause axonal 
damage as well as deposition of Aβ and in white matter in the hours after injury as 
well as increases in intracellular levels of Aβ and tau.  It was also predicted that 
overall levels of APP, Aβ and normal and hyperphosphorylated tau would be 
increased. 
 
To investigate the effect of mild TBI on Aβ, tau and white matter pathology in a 
transgenic mouse model of AD, axons, myelin, Aβ and tau as well as the levels of 
axonal and AD-related proteins were examined at 24 hours after mild TBI. 
 
Chapter 5: Effect of chronic cerebral hypoperfusion on white matter and cognition in 
mice 
 
Chronic cerebral hypoperfusion was hypothesised to cause damage to elements of 




To investigate the effects of chronic cerebral hypoperfusion on cognition and white 
matter pathology in wild-type mice, axonal and myelin damage as well as a number 
of cognitive domains were investigated after one or two months of hypoperfusion. 
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2 Materials and methods 
 
2.1 Animals and surgical techniques 
 
All animals were housed on a 12 hour light/dark cycle and had access to food and 
water ad libitum, except during radial arm maze testing, where food intake and the 
weights of individual mice were monitored continuously.  All animals were kept on a 
12 hour light/dark cycle.  All experiments were carried out under a UK Home Office 
licence and adhered to regulations specified in the Animals (Scientific Procedures) 
Act (1986). 
 
The wild-type strain used in both mild traumatic brain injury (TBI) and 
hypoperfusion studies was C57Bl/6J (Charles River, UK).  In the study of the effects 
of mild TBI on white matter and Alzheimer’s disease (AD) pathology a triple 
transgenic (3xTg) mouse model of AD as described by Oddo (2003).  These mice 
express human APPSwe, and tauP301L transgenes under a Thy1.2 promoter as well as 
the M146V mutation knocked into murine PS1.  Mice were originally derived by 
microinjection of the transgenes into single-cell embryos from homozygous 
PS1M146V knockin mice and backcrossed onto the PS1M146V knockin strain.  Breeding 
was carried out in-house, breeding pairs having been originally obtained from the 




2.1.1 Induction of mild TBI 
 
Mild TBI was modelled using lateral fluid percussion injury (FPI; McIntosh, 1989) 
surgery and was carried out by Dr. Jill Fowler as previously described by Lifshitz 
(2008).  Wild-type animals were anaesthetized with 250 mg/kg avertin.  3xTg 
animals were anaesthetised in an anaesthesia chamber with 5% isoflurane in 30:70 
mixture of oxygen and nitrous oxide for 5 minutes and maintained with 1.5% 
isoflurane anaesthesia via a nose cone while the craniotomy was drilled.  A 3mm 
craniotomy was drilled between bregma and lambda over the right parietal cortex, 
leaving the underlying dura intact.  Animals in which the dura was breached were 
excluded from the study.  A modified Luer-Lok hub (BD Biosciences, Oxford, UK) 
was placed over the craniotomy site and secured with cyanoacrylate glue and methyl 
methacrylate cement.  After recovery (24 hours for avertin anaesthetised animals and 
at least 1 hour for isoflurane anaesthetised animals) mice were reanaesthetised in a 
chamber using 5% isoflurane in 30:70 mixture of oxygen and nitrous oxide for 5 
minutes.  Once anaesthetised, animals were connected to the fluid percussion device 
(McIntosh et al., 1989) via high pressure tubing and a fluid pressure pulse was 
delivered.  Sham control animals underwent the same procedure, including 
connection to the fluid percussion device but did not receive a fluid pressure pulse.  
The injury hub was then removed.  Following this animals were placed on their 
backs and the righting time recorded, as a measure of injury severity.  Animals were 
then reanaesthetised as before and maintained with 1.5% isoflurane anaesthesia via a 




2.1.2 Induction of chronic cerebral hypoperfusion 
 
Chronic cerebral hypoperfusion was induced as described previously (Shibata et al., 
2004) and surgery was carried out by Dr. Karen Horsburgh.  Animals were 
anaesthetised in a chamber with 5% isoflurane in a mixture of 30:70 oxygen:nitrous 
oxide and maintained with 1.5% isoflurane anaesthesia via a nose cone.  The 
common carotid arteries were exposed via midline cervical incision.  Microcoils of 
0.18 mm diameter (Sawane Spring Co., Hamamatsu, Japan) were placed around the 
common carotid arteries with a 30 minute interval between the insertion of the first 
and second microcoils.  Sham animals underwent the same surgical procedure as 
hypoperfused animals, with the exception of the placement of microcoils.  At the end 
of the surgical procedure the incision was sutured. 
 
2.2 Behavioural testing 
 
Prior to surgery all animals designated for behavioural testing were handled for 5 
minutes per day for 5 consecutive days to minimise stress resulting from handling.  
All behavioural testing was carried out by pairs of experimenters blinded to the 




2.2.1 Morris water maze 
 
All water maze testing was carried out in a 2m diameter tank filled with water to a 
depth of 50cm, at a temperature of 25 ± 1°C and rendered opaque by the addition of 
liquid latex.  The experimental room was painted white and equipped with a variety 
of 3D and 2D cues in contrasting colours to improve their salience (Figure 2.1).  
Timing of latencies to the platform, tracking of swim patterns in all versions of the 
water maze task and control of the submerged platform in the probe tests was done 
using the WaterMaze video tracking system (v 2.6, ActiMetrics Software). 
 
2.2.2 Cued platform testing in the Morris water maze 
 
Animals were trained on a cued version of the water maze task for 1 day prior to 
surgery in order to exclude animals that showed an abnormal stress response to the 
task.  In this task the target platform was 20cm in diameter and was marked by a 20 
cm high cue and was located in a different quadrant for each trial on a given day.  
The platform was submerged 1cm below the surface of the water.  A white curtain 
was drawn around the pool to preclude the use of any extramaze cues to find the 
platform in this task. 
 
Training on the cued version of the water maze task was repeated for four days, 
beginning 1 week after surgery.  Each animal was trained for 4 trials per day, with 20 
minutes between trials.  Training in the cued version of the water maze task was 
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carried out to establish the presence of gross motor or visual impairments and to train 
the animals to swim to and climb on to a submerged platform.  At the start of each 
trial the animal was placed in the pool, facing the wall and allowed to swim until 
finding a platform centred in one of the quadrants of the pool or until 90 seconds had 
expired.  Mice were placed in the pool at one of the four cardinal points (north, 
south, east and west), with the start position varying for each trial so that the no 
starting position was repeated on any day. 
 
2.2.3 Spatial reference learning and memory in the Morris water maze 
 
Spatial reference memory training began 3 days after the end of the cued platform 
water maze task.  The 13cm diameter platform was not visible to animals in this task; 
being submerged 1cm below the surface of the water and uncued.  Animals were 
trained over 5 days for 4 trials per day and the platform remained in a constant 
location for each animal throughout testing, while the start location varied.  The 
platform locations and start positions used were counterbalanced across groups.  
Prominent extra maze cues were available throughout the room.  Probe tests were 





2.2.4 Episodic memory in the Morris water maze 
 
Episodic memory was tested using a trials to criterion protocol as described by Chen 
et al. (2000).  Testing began 3 days after the end of the cued platform water maze 
task.  The platform used in this task was the same as used during spatial reference 
memory testing.  Animals learned a series of platform locations to a criterion of 
performance.  Trials were conducted in the same way as in the spatial reference 
memory protocol.  The criterion used was an average latency to reach the platform of 
less than 20 seconds over 3 consecutive trials.  Animals were permitted a maximum 
of 32 trials to reach this criterion, except for the first platform location, where the 
maximum number of trials permitted was 40.  The maximum number of trials per 
day was 8.  After reaching criterion or 32 trials, training on that platform location 
ended and memory for the platform location probed as described below at 10 minutes 
and 3 hours after the end of training.  On the next day training began on a new 
platform location.  Animals continued to learn a sequence of platform locations for a 
minimum of 10 days or until 5 platform locations had been learned.  Probe tests were 
carried out only after the first 5 platform locations.  Platform locations and start 
positions used were counterbalanced across groups. 
 
2.2.5 Probe testing in the Morris water maze 
 
During probe testing the 13cm diameter platform was submerged at the bottom of the 





Figure 2.1: Water maze dimensions and cues 
The water maze (A) had a diameter of 200cm.  The diameter of the platform in the cued version of the water maze task was 
20cm and the diameter of the platform in the spatial reference memory task had a diameter of 13cm.  There were numerous 





platform was made available in the same position as it had been in the preceding 
training period and the mouse allowed a further 30 seconds to locate it, in order to 
minimise extinction of the platform finding behaviour. 
 
2.2.6 Working memory testing in the radial arm maze 
 
Working memory was tested using an 8-arm radial maze protocol adapted from 
Shibata et al. (2007).  The maze and its dimensions are shown in Figure 2.2.  Doors 
at the proximal end of each arm were controlled remotely using Any-Maze software 
(Stoelting, Dublin, Ireland).  Each arm was enclosed by a 20cm high transparent 
perspex wall.  Tracking of the animals in the maze was carried out using the same 
software.  The experimental room was equipped with both 2D and 3D cues in colours 
that contrasted with the white walls of the room.  Food deprivation began 3 weeks 
after surgery and animals were maintained at 85 – 90% of initial bodyweight 
throughout testing.  Pre-testing was carried out both to acclimatise animals to the 
maze environment and to train the animals to retrieve food pellets from the plastic 
food wells located at the end of each arm.  On the first pre-training day food pellets 
(Bio-Serv, USA) were scattered about the maze and the animal allowed to explore 
freely for 5 minutes.  On the second pre-training day food pellets were placed in each 
of the food wells and the animal placed in the central platform.  The animal was 
allowed to retrieve the food pellet from each arm in turn. 
 
For each trial of the spatial working memory task all 8 arms were baited with food 





Figure 2.2: Radial arm maze dimensions and cues 
The central reservation of the radial arm maze (A) had a diameter of 20cm while the arms of the maze were 47cm long and 
7cm wide.  A food well of 3.5cm diameter was located at the end of each arm.  Each arm was enclosed by a 20cm high 
transparent wall and could be opened and closed by means of remotely operated transparent doors (B).  The room in which 





with all doors open.  An arm choice was recorded when the centre of the mouse had 
travelled 5cm along the arm.  An arm choice triggered closure of the doors to the 
other 7 arms.  When the animal returned to the central platform it was confined there 
for 5 seconds before being allowed to make another arm choice.  The trial ended 
when the animal had retrieved all 8 food pellets or when 25 minutes had elapsed.  
Each animal completed 1 training trial per day.  After 16 days of training a 2 minute 
delay was introduced after the fourth arm choice.  This assessed the effects of 
increasing the load on working memory in the task.  Training on this protocol 
continued for 4 further trials 
 
.2.3. Perfusion fixation 
 
Animals selected for histological or immunohistochemical analysis were terminated 
by transcardiac perfusion.  Animals were deeply anaesthetised with 5% isoflurane in 
an anaesthetic chamber.  Depth of anaesthesia was assessed by presence or absence 
of reaction to hindpaw pinch.  Once animals showed no reaction to this test they 
were moved to a mask for maintenance of anaesthesia during the procedure.  The 
thoracic cavity was opened and the diaphragm exposed.  The diaphragm was cut 
through to expose the heart, which was gently freed of connective tissue.  A needle 
was inserted into the left ventricle and clamped in place and an incision was made in 
the right atrium.  Animals were perfused with 20mL of heparinised 0.9% saline in 
phosphate buffer via the clamped needle; fixation was achieved by perfusion with 
4% paraformaldehyde in phosphate buffer (pH = 7.4).  The animals were decapitated 
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and the scalp cut back to expose the skull and the entire head placed in 4% 
paraformaldehyde in phosphate buffer overnight.  The following day the brain was 
removed from the skull and returned to the paraformaldehyde solution for 2 hours 
before removal to phosphate buffer for storage up to 2 days prior to paraffin 
embedding.  In cases where the quality of perfusion was sub-optimal (as determined 
by the rigidity of the limbs) the brain was removed from the skull immediately 
following decapitation and placed directly into 4% paraformaldehyde solution 
overnight before removal to phosphate buffer solution. 
 
2.4 Paraffin embedding and sectioning 
 
Brains of C57Bl/6J mice in the initial FPI studies were divided into 3mm thick 
coronal sections prior to paraffin embedding.  Sections were placed in embedding 
cassettes and dehydrated through successive alcohols and xylene into paraffin in the 
sequence described in Table 2.1 
 
In studies using 3xTg mice whole brains were dehydrated and prepared for paraffin 
embedding in a Tissue Tek VIP 2 (Sakura Finetek Europe, Alphen aan den Rijn, The 
Netherlands) automatic tissue processor in the sequence described in Table 2.2 
 
Following processing brains were embedded in fresh paraffin, mounted on a plastic 
cassette and allowed to set at room temperature.  Paraffin embedded tissue blocks 
were cut at 6μm on a microtome prior to mounting on poly-L-lysine coated slides 
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Solution Duration Temperature 
70% Ethanol 2 x 30 mins Room temperature 
90% Ethanol 2 x 30 mins Room temperature 
100% Ethanol 2 x 30 mins Room temperature 
Xylene 2 x 30 mins Room temperature 
Paraffin wax 3 x 30 mins 65°C 
Paraffin wax Overnight 65°C 
 
Table 2.1: Manual processing of brains for paraffin embedding 
Sequence of solutions used and time spent in each for manual preparation of  




Solution Duration Temperature 
50% Ethanol 60 mins 35ºC 
80% Ethanol 60 mins 35ºC 
95% Ethanol 60 mins 35ºC 
100% Ethanol 60 mins 35ºC 
100% Ethanol 90 mins 35ºC 
100% Ethanol 120 mins 35ºC 
100% Ethanol 60 mins 35ºC 
Xylene 3 x 60 mins 35ºC 
Paraffin wax 3 x 60 mins 60ºC 
Paraffin wax Hold for at least 60 mins 60ºC 
 
Table 2.2: Automatic processing of brains for paraffin embedding 
Sequence of solutions used and time spent in each for automatic preparation  




(SuperFrost, Menzel-Gläser, Braunschweig, Germany) or charged slides (SuperFrost 




Slides containing sections from the level corresponding to -1.94mm from bregma 
according to Franklin and Paxinos (1997) were selected for staining with 
haematoxylin and eosin (H&E) and fluoro-jade C (FJC) to determine the presence of 
neuronal damage.  All analyses were carried out by a single blinded experimenter 
 
.2.5.1 Haematoxylin and eosin staining 
 
Sections were deparaffinised in an oven at 60°C for 30 minutes and then in xylene 
for 15 minutes.  They were then rehydrated through graduated alcohol solutions and 
running tap water.  Sections were immersed in Gill’s haematoxylin solution (Thermo 
Fisher, Loughborough, UK) for 35 seconds and then rinsed briefly in running tap 
water.  Staining was differentiated in a solution of 1% HCl in 70% ethanol for 8 
seconds and sections were then washed in running tap water for 2 minutes.  
Immersion in Scott’s tap water solution (2% MgSO4, 0.35% NaHCO3) for 2 minutes 
achieved blueing of the nuclei, this was followed by a two minute wash in running 
tap water.  Sections were then placed in eosin Y solution (Surgipath, 
Cambridgeshire, UK.) for 2 minutes and washed again for 2 minutes in running tap 
water before dehydration in graduated alcohols and xylene.  Sections were then 
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mounted and coverslipped using DPX mounting medium (Thermo Fisher, 
Loughborough, UK) 
 
2.5.2 Fluoro-jade C staining 
 
The fluoro-jade C (FJC) staining protocol was adapted from Schmued et al. (2005).  
Sections were deparaffinised and rehydrated as described for haematoxylin and eosin 
(H&E) staining.  Sections were washed for 2 minutes in distilled water followed by 
transfer to 0.06% potassium permanganate solution for 15 minutes.  After three 1 
minute washes in distilled water, sections were placed in a 0.0001% solution of FJC 
(Millipore, Watford, UK) in 0.1% acetic acid for 10 minutes.  Sections were again 
given three one minute washes in distilled water and dried in an oven at 60°C before 
clearing in xylene and coverslipping and mounting in DPX. 
 
2.5.3 Quantification of neuronal damage 
 
Damage to neuronal perikarya was assessed using FJC or H&E stained sections in 
the cortex, hippocampus and dorsal thalamus. 
 
In H&E stained sections the presence or absence of damaged eosinophilic neurons 
was recorded.  Damaged neurons appeared pyknotic and were distinguishable from 





In FJC stained sections the presence or absence of fluorescent, damaged neurons was 
noted.  Damaged neuronal cell bodies were identifiable as green fluorescently 




One section adjacent to those used for histological staining was selected from each 
animal for each of the immunohistochemical stains used.  All analyses were carried 
out by a single blinded experimenter. 
2.6.1 Immunohistochemistry 
 
Sections were deparaffinised and rehydrated as described for H&E staining.  
Endogenous peroxidase activity was blocked by immersion of sections in a solution 
of 3% H2O2 in methanol for 30 minutes.  Sections were then washed for 10 minutes.  
Antigen retrieval was performed at this stage as necessary (see Table 2.3).  Two ten 
minute washes in phosphate buffered saline (PBS) preceded incubation for 1 hour at 
room temperature in a solution of 0.5% bovine serum albumin and 10% normal 
serum in PBS to block non-specific binding.  After incubation the blocking solution 
was drained off and primary antibody solution made in blocking solution was applied 
and sections incubated overnight at 4°C.  Sections were then washed twice for ten 
minutes in PBS before application of the appropriate biotinylated secondary antibody 
made in PBS at a dilution of 1:100 for 1 hour at room temperature.  Following two 
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further 10 minute washes in PBS sections were incubated for 1 hour in an avidin-
biotin-peroxidase complex solution (Vector Labs, Peterborough, UK) then given two 
washes in PBS for 10 minutes.  Sections were developed by incubation with 3,3'-
diaminobenzidine (Vector Labs, Peterborough, UK) for 3 minutes before washing for 
10 minutes in running water and dehydration through graduated alcohol solutions as 
described for haematoxylin and eosin staining.  Sections were mounted and 
coverslipped with DPX.  Prior to dehydration sections stained against myelin 
associated glycoprotein (MAG) were counterstained with haematoxylin using the 
same procedure as described for H&E staining.  Sections were dehydrated and 
mounted following the blueing step. 
 
Details of the primary antibodies used, along with their corresponding secondary 
antibodies, normal sera and antigen retrieval protocols are listed in Table 2.3.  
Optimal concentrations for primary antibody use were determined by testing a range 
of dilutions in sections from the same animals in which staining was to be carried 
out. 
 
In the case of staining sections from 3xTg mice with primary antibodies raised in 
mouse, a high level of non-specific staining from the anti-mouse secondary was 
found, possibly due to an elevated inflammatory response to injury in these animals.  
In these instances a “Mouse on Mouse” kit (Vector, Peterborough, UK) was used to 
decrease undesirable staining.  This necessitated the following changes to the 
staining protocol.  After antigen retrieval or blocking of endogenous peroxidases the 
mouse on mouse blocking reagent was applied for 30 minutes at room temperature. 
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Microwaved for 10 
minutes in 0.01mol/L 
and left to cool for 30 
minutes 
Horse Anti mouse 
Amyloid β 4G8 
Millipore, Watford, UK 1:250 
10 minutes in 80% 
formic acid 




Myelin basic protein 
(MBP) 












Horse Anti goat 
Normal human tau HT7 
Source Bioscience, 
Nottingham, UK 
1:1000 N/A Horse Anti mouse 
Tau 
hyperphosphorylated 





1:150 N/A Horse Anti mouse 
 
Table 2.3: Details of antibodies used in immunohistochemistry studies 
Details of the antibodies used for immunohistochemical staining, including supplier, working dilution, antigen retrieval and  
appropriate secondary antibodies and normal sera. 
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Sections were then washed in PBS and blocked for 1 hour in protein concentrate 
solution.  After draining off the protein concentrate solution primary antibody, 
diluted in protein concentrate solution was applied overnight at 4°C.  Following 
washing in PBS, sections were incubated for 1 hour in biotinylated anti-mouse 
secondary antibody from the kit.  From this point on the protocol was carried out as 
usual.  When assessing amyloid precursor protein (APP) and amyloid β staining in 
white matter this kit was found to decrease staining in white matter close to the 
injury site so analyses of white matter pathology using these antibodies were carried 
out in sections stained in the previously described manner by Mr. Tommy Dingwall. 
 
2.6.2 Quantification of axonal damage 
 
Axonal pathology was assessed in the cingulum, corpus callosum, cortex, external 
capsule, internal capsule and in the dorsal thalamus.  Axonal damage was identified 
in APP immunostained sections and defined as the presence of intense APP 
immunoreactivity in swollen or bulbous axons (McKenzie et al., 1996). 
 
A counting grid of defined area was used to count axonal bulbs per mm
2
 of each 
region.  Counting was carried out at 600x magnification on an Olympus BX51 
(Olympus UK, Southend-on-Sea, UK) microscope in the study of wild-type mice and 
at 400x magnification on a Leica DMR microscope (Leica microsystems, Milton 
Keynes, UK) in the 3xTg study.  Counts were conducted twice, on separate days and 
an average taken, these values underwent the transformation log10(count + 1) before 
analysis.  The total area sampled in each region in the studies in wild type mice was 
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as follows; cingulum 0.0028mm
2
, corpus callosum, external capsule, internal capsule 
0.0056mm
2
; cortex, thalamus 0.0556mm
2
.  The total area sampled in each region in 
the studies in 3xTg mice was as follows; cingulum 0.0063mm
2
, corpus callosum, 
external capsule, internal capsule 0.0125mm
2
; cortex, thalamus 0.125mm
2
.  To 
establish the reproducibility of this technique, slides were taken from 3 animals at 
random for each study.  Damaged axons were counted as described above 3 times.  If 
results were within 10% of the median score reproducibility was deemed to be 
sufficient. 
 
2.6.3 Quantification of myelin damage 
 
Myelin integrity was assessed in MBP immunostained sections.  Relative optical 
density (ROD) values were measured using an image analysis system (MCID 7.0, 
InterFocus Imaging Ltd, Cambridge, UK) and QImaging QICAM Fast 1394 camera 
(QImaging, Surrey, BC, Canada) connected to a microscope (Leica Microsystems 
UK, Milton Keynes, UK).  Measurements for all cases were taken at the same light 
intensity at 100x magnification.  ROD readings were taken in the cortex, cingulum, 
corpus callosum, external capsule, internal capsule and in the dorsal thalamus.  Eight 
ROD measurements were taken from each region bilaterally using a sampling box of 
0.01mm
2
 in the cortex and thalamus and of 0.001mm
2
 in all other regions.  ROD 
values were averaged for each region and ipsilateral measurements expressed as a 
percentage of the corresponding contralateral measurement to control for possible 
differences in exposure time during staining.  In order to establish the reliability of 
this technique slides from three animals were chosen at random from each group of 
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animals to be examined and analysed as described three times.  The measure was 
deemed reproducible when the 3 measurements fell within 10% of the median value. 
 
Due to variations between the regions in the appearance of normal staining, 
particularly, the low level of staining in the thalamus, image analysis of MAG 
immunostaining was not possible.  Instead myelin integrity as indicated by the 
presence of myelin debris was graded in MAG immunostained sections based on 
photographs of the cingulum, corpus callosum, external capsule, internal capsule and 
thalamus taken at 200x magnification on a Leica DMR microscope (Leica 
Microsystems UK, Milton Keynes, UK) using a QImaging QICAM Fast 1394 
(QImaging, Surrey, BC, Canada).  Myelin debris appeared as small, darkly stained 
points in white matter.  The grade assigned to the pathology present in each structure 
was based on the most severe pathology evident in that structure.  In studies in wild-
type mice the grades were defined as follows; normal, even staining of white matter 
(grade 0), minimal myelin debris (grade 1), modest myelin debris (grade 2).  
Examples of each grade are shown in Figure 2.3.  Reproducibility of MAG 
quantification was established was again established by selecting slides from 3 
animals at random and grading carried out three times as described above.  
Assessment was regarded as reproducible when the grades assigned in each 
assessment agreed.  In 3xTg mice damage was assessed as present or absent as the 
low levels of damage in this group meant it was not possible to reliably differentiate 






Figure 2.3: Grading scale of damage visualised using MAG 
immunostaining in wild–type mice following FPI 
Myelin damage visualised using MAG staining was graded on a scale from 0 
to 2 in the cingulum.  The grades were defined as follows; normal, even 
staining of white matter (grade 0), minimal myelin debris (green arrows), 
vacuolation, and disorganisation of fibres (grade 1), modest myelin debris 





2.6.4 Quantification of amyloid β pathology 
 
Immunostaining for amyloid β was assessed in both white matter and in cell bodies.  
Amyloid β staining in white matter tracts was defined as the presence of darkly 
stained bulbs.  This staining was quantified in the same way as APP staining in 
studies involving 3xTg mice (above).  Reproducibility was also established in the 
same way as for APP staining. 
 
Intracellular staining was measured in the amygdala, cortex and the CA1, CA2, CA3 
and dentate gyrus subfields of the hippocampus.  Images of these regions were taken 
at 100x magnification on an Olympus BX51 microscope (Olympus UK, Southend-
on-Sea, UK) using a QImaging MicroPublisher 3.3 camera (QImaging, Surrey, BC, 
Canada).  Images were converted to greyscale and the percentage surface area 
stained in each region photographed was measured in ImageJ (U. S. National 
Institutes of Health, Bethesda, USA).  Values obtained in this way underwent the 
transformation log10(count + 1) before analysis.  The total area sampled in each 




; CA1 and CA3 
0.08mm
2
; CA2 and dentate gyrus 0.04mm
2
.  Reproducibility was established 
similarly to other techniques, with a random selection of three animals being 





2.6.5 Quantification of tau pathology 
 
Normal human tau was quantified and reproducibility established in the same way as 
intracellular amyloid β staining. 
 
As the amount of staining of abnormally phosphorylated tau visualised was very low, 
this staining did not lend itself to quantification and the presence or absence of 
abnormally phosphorylated tau in the cingulum, corpus callosum, cortex, external 
capsule, internal capsule and in the dorsal thalamus was recorded.  In white matter 
regions positive staining appeared as darkly stained spheroids, while in the grey 
matter areas immunopositive neurons were recorded. 
 
2.7 Tissue preparation 
 
Animals selected for biochemical analysis following FPI were terminated by cervical 
dislocation.  The brains were removed and a 4mm coronal section of tissue around 
the injury site was dissected out.  The hypothalamus was removed and the section 
divided into hemispheres.  Dissections were carried out on ice.  The pieces of tissue 
were placed in labelled eppendorf tubes and snap frozen on liquid nitrogen before 




2.7.1 Tissue homogenisation 
 
Tissue for biochemical analysis was homogenised in buffer containing 250mM 
sucrose, 20mM Tris Base, 1mM (ethylenediaminetetraacetic acid) EDTA and 1mM 
(ethylene glycol tetraacetic acid) EGTA in distilled water.  Protease and phosphatase 
inhibitors (Merck, Nottingham, UK) at concentrations of 1:100 and 1:50, 
respectively were added to the buffer.  After homogenisation with a Dounce 
homogeniser samples were mixed 1:1 with buffer containing 0.4% diethylamine and 
0.1M NaCl.  Samples were spun for 5 minutes at a rotor speed of 3000 rpm in a 
Sigma 1-13 benchtop centrifuge (Sci Quip Ltd., Shrewsbury, UK) and the 
supernatant removed and stored at -80°C before use. 
2.7.2 Determination of protein content of samples 
 
The amount of protein present in samples was determined using a bicinchoninic acid 
protein assay kit (Thermo Fisher Scientific, Cramlington, UK).  Samples and 
standards were diluted 1:7 in distilled water and loaded in triplicate on to a 96-well 
plate.  The working reagent (consisting of a solution of sodium carbonate, sodium 
bicarbonate, bicinchoninic acid and sodium tartrate in 0.1M sodium hydroxide mixed 
50:1 with 4% cupric sulphate solution) was added and the plate incubated at 37°C for 
30 minutes.  The plate was cooled to room temperature before the absorbance was 
read at 562nm on a Dynex MRX plate reader (Dynex Technologies Ltd., Worthing, 
UK).  Values obtained from protein standards were used to generate a standard curve 




2.8 Western blotting 
 
2.8.1 Western blotting 
 
Samples were made up to concentrations of either 1µg/µL or 0.5µg/µL with 0.25µL 
of 4x Laemelli buffer per µL and the same buffer containing 250mM sucrose, 20mM 
Tris Base, 1mM EDTA and 1mM EGTA in distilled water that was used in the 
homogenisation procedure.  Control sample, consisting of tissue from two 
experimentally naïve 10 month-old 3xTg mice was prepared in the same way. 
Proteins were denatured by incubation at 70°C for 10 minutes on a water bath and 
loaded on to precast 4-12% Bis/Tris gels (Invitrogen, Paisley, UK) along with 
molecular weight marker (Li-Cor, Cambridge, UK).  Control samples were loaded 
twice on each gel.  Proteins were separated by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) electrophoresis with 2-(N-
morpholino)ethanesulfonic acid (MES) running buffer (Invitrogen, Paisley, UK).  
Samples were run at 80V through the stacking gel (45 minutes) and at 120V to the 
bottom of the gel (1.5 to 2 hours), except where APP C-terminal fragments were to 
be detected when samples were run at 80V to the bottom of the gel. 
 
Proteins were transferred to a polyvinylidene fluoride (PVDF) membrane (GE 
Healthcare, Little Chalfont, UK) at 30V for 2.5 hours in an XCell II™ Blot Module 
(Invitrogen, Paisley, UK).  Transfer success and evenness of loading was estimated 
by staining gels in Coomasie Blue (Bio-Rad, Hemel Hempstead, UK) for one hour.  
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Gels that had not transferred well or where loading was uneven across the gel were 
excluded and repeated.  Membranes were rinsed in PBS and placed in light proof 
boxes and incubated in Odyssey blocking buffer (Li-Cor, Cambridge, UK) made 1:1 
with PBS for one hour.  Blocking buffer was then drained off and primary antibody 
made in blocking buffer and also containing anti glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) at a concentration of 1:100000 and 0.1% tween-20.  The 
anti-GAPDH antibody that was added to the solution was raised in a different species 
to the primary antibody of interest.  Membranes were incubated in primary antibody 
overnight at 4°C.  Membranes were washed six times for 5 minutes in PBS 
containing 0.1% tween-20 before incubation for 45 minutes in a solution of the 
appropriate secondary antibodies tagged with fluorescent infra-red dye (Li-Cor, 
Cambridge, UK) made at a concentration of 1:3000 in blocking buffer containing 
0.1% tween-20 and 0.01% sodium dodecyl sulphate (SDS).  The two secondary 
antibodies used were tagged with dyes that fluoresced at different wavelengths.  
Membranes were again washed six times for 5 minutes in PBS before finally being 
washed in PBS before drying and scanning on an Odyssey infrared scanning system 
(Li-Cor, Cambridge, UK). 
 
Details of the primary antibodies used, including concentrations, appropriate 





2.8.2 Quantification of protein levels 
 
The scanned images from the blots were analysed using Odyssey application 
software (version 3.0; Li-Cor, Cambridge, UK) to quantify the intensity of 
fluorescence of the protein bands of interest.  Western blots were run twice for each 
antibody.  The intensity values for the proteins of interest were expressed as a ratio 
of the intensity of the GAPDH band to control for variation in loading.  Bands where 
there was evidence of bubbles or other noise were excluded from analysis.  The 
values obtained from the two Western blots were averaged for analysis.  The 
intensity of the GAPDH band was also averaged across gels and an independent 
samples t-test used to compare the values obtained for each group.  This was to rule 
out the presence of a systematic loading bias and was repeated for every set of 
Western blots conducted.  In all cases there was no difference in the intensity of the 
GAPDH band between the groups (p > 0.05 in all cases).  Reproducibility of the gel 
was established by visual comparison of the blots as well as plotting the values 
obtained in each blot analysed for a given protein on the same axes and visually 
assessing whether the values obtained showed the same pattern of increases and 
decreases.  A representative example of GAPDH values obtained for each group 






Primary antibody Clone Supplier Dilution Secondary antibody 
Amount of protein 
loaded 
Amyloid precursor protein 
(APP) 
22C11 Millipore, Watford, UK 1:3000 Anti mouse 10µg 
APP C-terminal fragments Polyclonal Merck, Nottingham, UK 1:1000 Anti rabbit 30µg 
Myelin basic protein (MBP) 12 Millipore, Watford, UK 1:10000 Anti rat 5µg 
Normal human tau HT7 
Source Bioscience, 
Nottingham, UK 
1:1000 Anti mouse 10µg 
Tau hyperphosphorylated at 
S202 (AT8) 
AT8 
Thermo Fisher Scientific, 
Cramlington, UK 
1:500 Anti mouse 20µg 
Glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) 
GAPDH-71.1 Sigma-Aldrich, Dorset, UK 1:100000 Anti mouse N/A, dependent on 




Polyclonal Sigma-Aldrich, Dorset, UK 1:100000 Anti rabbit 
 
Table 2.4: Details of antibodies used in Western blotting studies 






Figure 2.4: Reproducibility of Western blots and determination of the  
absence of loading bias 
Reproducibility of Western blots was determined by comparison of the values 
obtained from each blot to determine whether the pattern of values obtained 
for the samples was similar.  (A) shows reproducible data from AT8 Western 
blots.  (B) Analysis of the intensity of the GAPDH band between groups 
revealed no significant differences between sham and injured animals.  This 
analysis was conducted for every Western blot carried out.  (B) shows  




2.9 Dot blot for oligomeric amyloid β 
 
2.9.1 Dot blot 
 
Homogenised samples were diluted in PBS so that they contained 2µg of protein per 
110µL.  Control samples were prepared in the same way from the same tissue used 
as control sample in Western blotting.  An activated nitrocellulose membrane was 
loaded in to a dot blot apparatus (Bio-Rad, Hemel Hempstead, UK) and samples 
loaded on to the membrane in duplicate.  Samples were drawn through the membrane 
by means of a vacuum pump and the membrane placed in a light proof box in 
Odyssey blocking buffer (Li-Cor, Cambridge, UK) made 1:1 with PBS for one hour.  
The blocking buffer was then drained off and antibody against oligomeric amyloid β 
(clone A11; Millipore, Watford, UK) made in blocking buffer at a concentration of 
1:500 and also containing 0.1% tween-20 was added.  The membrane was incubated 
in primary antibody overnight at 4°C.  The membrane was then washed six times for 
5 minutes in PBS containing 0.1% tween-20.  Following this, the membrane was 
incubated in a 1:3000 solution of anti mouse secondary antibody tagged with 
fluorescent infra-red dye (Li-Cor, Cambridge, UK) made with blocking buffer 
containing 0.1% tween-20 and 0.01% SDS for 45 minutes.  The membrane was again 
washed six times for five minutes in PBS containing 0.1% tween-20 then washed 
twice for 2 minutes in PBS.  The membrane was stored in PBS at 4°C until scanning 




2.9.2 Quantification of protein levels 
 
The scanned images were analysed using Odyssey application software (version 3.0; 
Li-Cor, Cambridge, UK) to quantify the intensity of fluorescence of each of the dots.  
Dot blots were run twice.  The values obtained from each replicate were averaged 
and expressed as a percentage of the control sample.  Dots where there was evidence 
of noise or that had not been drawn through the membrane properly were excluded 
from analysis.  The values from the two dot blots were averaged for analysis. 
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3 Effect of mild traumatic brain injury on pathology and 




White matter is particularly vulnerable to damage in traumatic brain injury (TBI), 
with damage to white matter being the primary pathology in human patients with 
mild TBI (Kraus et al., 2007; Sterr et al., 2006).  Additionally, mild TBI can result in 
persistent cognitive deficits (De Beaumont et al., 2009; Lipton et al., 2008; Matser et 
al., 1999) and predisposes individuals to an increased risk of developing Alzheimer’s 
disease (AD) (Guskiewicz et al., 2005), making this a potentially useful model for 
investigating the relationship between white matter pathology and AD. 
 
Characterisation of models of mild TBI is lacking in comparison to models of more 
severe injury levels.  Axonal pathology has been demonstrated to be a prominent 
feature of mild TBI in rodent models, in both the hours (Dikranian et al., 2008; Huh 
et al., 2008; Li et al., 2006) and weeks after injury (Laurer et al., 2001).  This axonal 
pathology is often observed in conjunction with variable levels of cell death, 
reflecting the variety of experimental models used to model mild injuries.  Use of the 
controlled cortical impact (e.g. Dikranian et al., 2008; Huh et al., 2008) and weight 
drop models (Tang et al., 1997a; b) has been shown to produce significant neuronal 
loss.  However, in the study of an injury level where damage occurs primarily to the 
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white matter, the relevance of models showing widespread neuronal loss is limited.  
Changes in myelin following mild TBI remain uncharacterised. 
 
Mild TBI-induced axonal damage in the absence of grey matter damage is associated 
with cognitive deficits measured from hours after injury (Li et al., 2006) to weeks 
(Long et al., 2009) however, to date no studies have been conducted to examine 
long-lasting cognitive changes associated with white matter damage, similar to what 
is observed in human mild TBI. 
 
3.1.1 Aims and hypotheses 
 
The study described in this chapter aimed to examine the effects of mild TBI on 
white matter and cognition.  To investigate this, a detailed examination of axons, 
myelin and neuronal cell bodies was undertaken at time points ranging from 4 hours 
to 6 weeks as well as an investigation of learning and memory 3 and 6 weeks after 
injury. 
 
It was hypothesised that mild TBI would cause selective damage to axons at short 
and long-term time points after injury as well as inducing a persistent deficit in 







3.2.1 Fluid percussion surgery and animals 
 
Male C57Bl/6J mice (Charles River, UK) weighing 24 – 30g underwent mild lateral 
FPI (injury severity = 0.9 ± 0.1atm) or sham surgery as described in chapter 2.1.  
Righting times for injured animals (217 ± 32 seconds) were significantly longer than 
for control animals (51 ± 9 seconds, p < 0.001).  Surgical procedures were carried 
out by Dr. Jill Fowler. 
 
3.2.2 Spatial reference memory testing in the Morris water maze 
 
Water maze testing was carried out according to the protocol detailed in chapter 2.2.  
Prior to behavioural testing animals were handled for 5 minutes per day for 5 
consecutive days to minimise stress resulting from handling.  In order to exclude 
animals showing an abnormal stress response one day of training on the cued version 
of the water maze task was carried out prior to surgery.  No animals were excluded 
on this basis from this study.  Training on the cued version of the water maze task 
was repeated for four days, beginning 1 week after surgery.  Each animal received 4 
training trials per day, with a 20 minute interval between trials.  Spatial reference 
memory training began 3 days after the end of training in the cued version of the 
task.  Animals were trained over 5 days with 4 trials per day and a 10 minute 
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intertrial interval.  Probe tests were carried out 10 minutes and 24 hours after the 
final trial of spatial reference training.  Beginning 2 weeks after this the same 
animals were retested using the same spatial reference memory training protocol in a 
different water maze with the same dimensions as the first but a different set of cues.  





Figure 3.1: Timeline of behavioural testing 
Animals were handled and pretested in the cued water maze task prior to 
injury.  Further testing on the cued task and in the spatial reference learning  





3.2.3 Histology and immunohistochemistry 
 
Animals that underwent behavioural testing (n = 7 sham, 10 injured) were sacrificed 
6 weeks after injury.  Further cohorts of animals were sacrificed at 4 hours (n = 4 
sham, 5 injured), 24 hours (n = 4 sham, 5 injured), 72 hours (n = 3 sham, 4 injured) 
and 4 weeks (n = 5 sham, 5 injured) after surgery for pathological investigation.  At 
termination animals were deeply anaesthetised and transcardially perfused with 20 
mL heparinised 0.9% saline in 0.1% phosphate buffer followed by 4% 
paraformaldehyde in 0.1% phosphate buffer.  Brains were postfixed and embedded in 
paraffin as described in chapter 2.4.  6 µm thick sections were cut and mounted in 
pairs on poly-L-lysine coated slides.  Slides containing sections from the level 
corresponding to -1.94mm from bregma according to Franklin and Paxinos  were 
selected for staining with haematoxylin and eosin (H&E) and fluoro-jade C (FJC) to 
determine the presence of neuronal damage.  A section from a mouse that had 
undergone transient focal ischaemia for 1 hour with 23 hours survival at the level 
corresponding to 0.50mm from bregma served as a positive control for FJC staining.  
Sections adjacent to those used for histological staining were selected for 
immunohistochemical staining.  Immunohistochemistry for amyloid precursor 
protein (APP) was performed to detect axonal damage.  Myelin damage was 
investigated using antibodies against myelin associated glycoprotein (MAG) and 
myelin basic protein (MBP).  The histological and immunohistochemical techniques 
used are described in detail in chapters 2.5 and 2.6.  The methods used to quantify 
neuronal, axonal and myelin damage are detailed in chapter 2.6.  Briefly, damage to 
neuronal perikarya was identified using FJC or H&E stained sections in the cortex, 
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hippocampus and dorsal thalamus.  In H&E stained sections the presence or absence 
of damaged eosinophilic neurons was recorded.  In FJC stained sections the presence 
or absence of fluorescent, damaged neurons was noted.  APP stained sections were 
used to count axonal bulbs per mm
2
 in the cingulum, corpus callosum, cortex, 
external capsule, internal capsule and dorsal thalamus.  Counts of axonal bulbs in 
APP stained sections were log transformed for analysis.  MBP stained sections were 
used to assess myelin integrity in the cortex, cingulum, corpus callosum, external 
capsule, internal capsule and in the dorsal thalamus.  Relative optical density (ROD) 
measurements were used to quantify myelin integrity in these sections.  ROD values 
were averaged for each region and ipsilateral measurements expressed as a 
percentage of the corresponding contralateral measurement to control for possible 
differences in exposure time during staining.  MAG staining was graded on a 3 point 
rating scale from 0 to 2 as illustrated in Figure 2.3. 
 
3.2.4 Statistical analysis 
 
Behavioural data were analysed using two-way ANOVA, using the Greenhouse-
Geiser correction where data were significantly not normally distributed (i.e. where 
Mauchly’s test returned a value of p < 0.05).  Post hoc comparisons were made using 
unpaired t-test.  Swim speeds from cued water maze testing were analysed using 
unpaired t-test.  Data from axonal counts and MBP image analysis were analysed 
using unpaired t-tests.  Data from grading of MAG staining were tested for 






3.3.1 Spatial reference learning is impaired 3 weeks after mild traumatic brain 
injury 
 
Both injured and sham animals decreased their latency to the cued platform over the 
training period (F(1.871,28.071) = 26.731, p < 0.001; Figure 3.2A).  There was no 
difference in performance between the injured and the sham-operated groups (F(1,15) 
= 2.698, p = 0.121).  Escape latencies averaged less than 10 seconds in both groups 
by the end of training.  Mean swim speed across all trials did not differ significantly 
between injured and sham-operated animals (20.756 ± 0.768 cm/s vs. 19.456 ± 0.957 
cm/s; |t| = 1.067, df = 15, p = 0.303 respectively, mean ± SEM). 
 
Mild TBI impaired the ability of animals to learn the location of a hidden platform 
(Figure 3.2B).  The latency for injured animals to find the platform did not change 
significantly over the five training days (F(4,36) = 1.401, p = 0.253).  The latency for 
sham animals to find the platform decreased significantly over the same training 
period (F(1.312,7.870) = 9.993, p = 0.011).  The performance of the two groups was 
significantly different from each other on days 4 (|t| = 2.175, df = 15, p = 0.046) and 
5 (|t| = 2.434, df = 15, p = 0.028) of testing.  Both groups showed the same degree of 
preference for the training quadrant when probed both 10 minutes (group x quadrant 
interaction, F(1.715,25.719) = 2.639, p = 0.098; Figure 3.2C) and 24 hours (group x 





Figure 3.2: Water maze performance 3 weeks after mild TBI in wild-type
mice 
Sham and injured mice both improved their performance in the cued version 
of the water maze task over the training period (A).  Injured mice did not 
significantly improve their latency to the hidden platform over the training 
days, while sham animals did (B).  Both groups also displayed equivalent 
retention of the training platform location at both 10 minutes (C) and 24 hours
after training (D).  Graphs show mean + SEM.  * = p ≤ 0.05 vs. sham.  adjL = 




3.3.2 No impairment of spatial reference learning and memory 6 weeks after mild 
traumatic brain injury 
 
At 6 weeks after injury both injured and sham animals decreased their latency to the 
platform significantly over the training days (F(4,36) = 7.100, p < 0.001 and F(4,24) = 
7.037, p = 0.001 respectively; Figure 3.3A).  Injured and sham animals showed no 
difference in their preference for the training quadrant when retention for the 
platform location was probed at 10 minutes (group x quadrant interaction, 
F(1.752,26.283) = 0.176, p = 0.912; Figure 3.3B) and 24 hours (group x quadrant 





Figure 3.3: Water maze performance 6 weeks after mild TBI in wild-type 
mice 
Sham and injured mice both improved their latency to the hidden platform 
over the training days (A).  Both groups also displayed equivalent retention of 
the training platform location at both 10 minutes (B) and 24 hours after 





3.3.3 Cell death is not increased following mild traumatic brain injury 
 
H&E staining identified damaged neurons which were distinguishable from dark cell 
change by their eosinophilic appearance and pyknotic nuclei (Figure 3.4, 
arrowheads; Jortner, 2006).  In the cortex local to the craniotomy site, nine of 
fourteen brain-injured animals and six of eleven sham-injured animals had moderate 
neuronal damage at 4, 24 and 72 hours after injury.  In both groups damage was 
confined to cortical layers I and II.  At 4 weeks after injury, only one of five brain-
injured animal displayed eosinophilic neurons in the hippocampus.  No damage was 
seen in any animal 6 weeks after injury.  Notably, in the hippocampus there was 
minimal evidence of neuronal damage in either the TBI or sham group and only 
isolated damaged neurons were observed in the CA1 of the ipsilateral hippocampus 
at 4, 24 and 72 hours after injury in both sham and injured animals and in 3 brain-
injured animals at 6 weeks after injury.  No damaged neurons were observed in the 
thalamus in either hemisphere at any time point (Appendix A.7). 
 
FJC staining identified damaged neuronal cell bodies by the presence of green 
fluorescently labelled cells against a dark background.  The pattern of damage 
observed in FJC stained sections mirrored that observed using H&E.  Damaged cells 
were seen almost exclusively in the cortex local to the craniotomy site.  Five out of 
nine brain-injured animals and six out of eight sham-injured showed damaged cells 
in this region at 24 and 72 hours after injury.  Four weeks after injury two of five 
brain-injured animals and one of five sham-injured animals displayed damage in this 
region and at 6 weeks after injury there was evidence of damage only in one injured 
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animal.  No FJC positive cells were observed in the hippocampus or thalamus in 
either hemisphere at any time point.  FJC positive cells were visible throughout the 






Figure 3.4: Cellular changes in the ipsilateral hemisphere after mild TBI 
Both injured and sham animals show damaged neurons in the cortex close to the injury site but not in the hippocampus or 
thalamus as demonstrated by H&E staining.  Arrowheads indicate damaged neurons.  Neuronal damage is most prominent at  
4 to 72 hours after injury and is absent at 8 weeks after injury. 
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3.3.4 Progressive axonal damage following mild traumatic brain injury 
 
Damaged axons were identified by the presence of intense APP immunoreactivity in 
swollen or bulbous axons (McKenzie et al., 1996).  Brain-injured animals showed 
extensive and localised axonal damage at all time points as compared to sham.  The 
location of the damage was time dependent.  In the short-term response to injury, 
axonal changes were confined to brain regions adjacent to the site of injury.  At 4 
hours after injury there was significantly more axonal damage in the ipsilateral 
cingulum of brain-injured animals than sham injured controls (|t| = 3.483, p = 0.010; 
Appendix A.1).  There were no significant differences between the groups in other 
regions at this time point.  At 24 and 72 hours after injury there were no significant 
differences in the levels of axonal damage observed in each of the two groups.  4 
weeks after injury brain-injured animals showed significantly higher numbers of 
axonal bulbs than shams in the external capsule (|t| = 2.433, p = 0.041).  Other 
regions were unaffected at this time point.  A significant difference between the 
groups was observed in the external capsule and thalamus at 6 weeks after injury (|t| 
= 2.377, p = 0.041 and |t| = 5.418, p < 0.001, Appendix A.4) while no differences 
were apparent in other regions examined.  Representative examples of APP 
immunostaining in the external capsule and thalamus at each time point are shown in 
Figures 3.5 and 3.6.  The pattern of change in axonal pathology in the ipsilateral 




3.3.5 No damage to myelin following mild traumatic brain injury 
 
In general, at all time points in all regions studied, there was minimal evidence of 
myelin pathology as assessed using either MAG or MBP immunostaining.  In MAG 
immunostained sections there was no evidence of small, darkly stained points of 
myelin debris in white matter at 4 (Appendix A.2) and 72 hours after injury in any 
region.  Two out of five injured animals showed mild to moderate debris 
accumulations in the ipsilateral cingulum, corpus callosum and external capsule at 24 
hours after injury but this was not significantly different from shams (cingulum; 0.0 
+ 0.9 vs. 0.0 ± 0.0, p = 0.730, corpus callosum; 0.0 + 0.5 vs. 0.0 ± 0.0 p = 0.413, 
external capsule; 0.0 + 0.9 vs. 0.0 ± 0.0, p = 0.413).  At 4 weeks after injury myelin 
debris was evident in the ipsilateral cingulum of two out of five injured animals this 
was not significantly different to sham animals (0.0 + 0.9 vs. 0.0 ± 0.0, p = 0.310).  
Two injured animals showed myelin damage in the ipsilateral internal capsule, this 
was not significantly different to sham animals (0.0 + 0.9 vs. 0.0 ± 0.0, p = 0.310).  
Six weeks after injury four out of 10 injured animals showed mild levels of myelin 
pathology in the ipsilateral cingulum and external capsule and two animals displayed 
mild debris accumulation in the internal capsule but this did not differ significantly 
from shams (cingulum; 0.0 + 0.5 vs. 0.0 + 0.8, p = 1.000, external capsule; 0.0 + 0.5 
vs. 0.0 ± 0.0 p = 0.193, internal capsule; 0.0 + 0.4 vs. 0.0 ± 0.0, p = 0.536; Appendix 
A.5).  There were no statistically significant differences in the levels of myelin 
pathology observed in sham and injured animals at any time point in any region.  
Representative examples of MAG immunostaining in the external capsule and 
thalamus are shown in Figure 3.8. 
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In general, at all time points in all regions studied there was minimal evidence of 
myelin pathology as assessed using MBP immunostaining.  In MBP immunostained 
sections there were no statistically significant differences in myelin integrity in any 
region at any time point.  Representative MBP staining results from 4 hours and 6 
weeks after injury are shown in Appendices A.3 and A.6.  Representative examples 
of MBP immunostaining in the external capsule and thalamus are shown in Figures 





Figure 3.5: Pattern of axonal and myelin changes in the ipsilateral external capsule from 4 hours to 6 weeks after 
mild TBI 
APP and MBP staining in the ipsilateral hemisphere over time after injury.  Significantly different levels of APP accumulation in 
the external capsule of injured animals as compared to shams were observed at 4 and 6 weeks after injury.  Green arrows  






Figure 3.6: Pattern of axonal and myelin changes in the ipsilateral thalamus from 4 hours to 6 weeks after mild TBI 
APP and MBP staining in the ipsilateral hemisphere over time after injury.  Significantly higher levels of APP accumulation in 
the thalamus of injured animals as compared to shams were observed at 6 weeks after injury.  Green arrows indicate





Figure 3.7: Changing location of damaged axons over time following mild TBI 
Regions where injured animals showed significantly higher numbers of damaged axons to sham controls varied across time 
after injury.  At 4 hours after injury damage was significantly higher in the cingulum of injured animals than in shams.  At 6 
weeks after injury the areas where injured animals showed increased axonal damage compared to shams were the external 







Figure 3.8: Examples of MAG immunostaining at time points up to 6 weeks after mild TBI 






Mild TBI is a source of persistent cognitive deficits and damage to white matter as 
well as a risk factor for AD.  Identification of potentially modifiable targets for 
treatment is necessary to reduce both impairment as a direct result of injury and the 
risk of developing AD in the future.  This requires relevant animal models of mild 
TBI in order to understand the pathology leading to cognitive impairment and the 
processes underlying the increased risk of AD after injury.  The current study 
examined pathological and cognitive changes after mild TBI.  The hypothesis that 
mild TBI would cause selective damage to axons was upheld with the observation of 
selective axonal pathology that showed a spatial progression over time after injury.  
The hypothesis that mild TBI would produce a persistent deficit in learning and 
memory was partially upheld with a deficit in spatial reference learning being 
observed at 3 but not 6 weeks after injury. 
 
Axonal pathology in this model was observed only in specific regions distinct to each 
time point investigated.  APP deposition was first visible in the cingulum close to the 
injury site.  Over the course of 6 weeks damage in the external capsule and dorsal 
thalamus became evident.  The spatial progression of axonal damage indicates a 
chronic degenerative process following injury and is illustrated in Figure 3.9.  Initial 
axonal damage may be due directly to changes induced by the injury such as 
dysregulation of ionic homeostasis, compression of the cytoskeleton (Meythaler et 





Figure 3.9: Changing locations of axonal damage up to 6 weeks after mild TBI 
The pattern of axonal damage in the model changes over time.  Damage is most evident in the cingulum at 4 hours after injury 
(A).  By 6 weeks after injury damage in these areas is most pronounced in the thalamus and external capsule (B). 
Damaged areas shown in red. 
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1996).  As degeneration progresses along the affected axons, damage becomes 
visible in regions sending out or receiving inputs from the damaged tracts.  Thalamic 
damage is predictable in such a model of degeneration, owing to the presence of 
thalamic projections in the cingulum (Domesick, 1970; Meunier and Destrade, 1988) 
and also indirect connections between the external capsule and thalamus through the 
internal capsule (Saper, 1984).  The specific projections involved in this study could 
not be identified from examination of a single coronal level. 
 
The rapid appearance of axonal damage following injury and its decrease from 24 to 
72 hours after injury is consistent with previous reports (Dikranian et al., 2008; Huh 
et al., 2008; Li et al., 2006).  A delay in the appearance of thalamic damage has 
previously been observed (Carbonell and Grady, 1999; Conti et al., 1998; Laurer et 
al., 2001) but is not a universal finding with some reporting that thalamic damage 
may be an acute event after injury (Dikranian et al., 2008; Huh et al., 2008).  The 
timing of the appearance of damage in the thalamus does not necessarily seem to be 
related to injury severity.  Instead, it may reflect heterogeneity of different models of 
mild TBI and the difficulty in comparing the relative severities of various models of 
TBI. 
 
Modelling axonal injury in mice differs mechanically from human injury owing to 
the small brain size of mice compared to humans.  The small mass of the mouse 
brain renders it less vulnerable to the shearing and tensile forces responsible for 
primary diffuse axonal injury in humans and making this type of injury difficult to 
replicate in mice (Marmarou et al., 1994; Ross et al., 1994).  The axonal injury 
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observed in this model is associated initially with the injury site, indicating that the 
injury itself, rather than shearing forces within the brain are responsible for the 
primary injury.  Despite the difference in the mechanics of how axons are initially 
damaged the presence of persistent damage after injury in both this model and 
humans points to common secondary mechanisms that could be potentially targeted 
for therapeutic intervention.  Currently treatment options for persistent cognitive 
deficits after mild TBI are limited and focused on alleviating cognitive symptoms 
without addressing underlying damage to the brain (Willer and Leddy, 2006).  The 
results presented here show that axons are suitable targets for prevention of future 
cognitive deficits.  Factors involved in axonal degeneration that have the potential to 
be beneficially modified include calpain activation and rises in intracellular calcium 
in order to maintain the structure of the neuronal cytoskeleton (Coleman, 2005). 
 
Previously, the myelin response to mild TBI has not been characterised and this 
study demonstrated unaltered myelination using MAG and MBP staining in regions 
where axonal damage was found.  Myelination remained unaltered up to 6 weeks 
after injury, suggesting that myelination at times between those investigated was also 
unaltered.  It is possible that the axons damaged after injury were unmyelinated.  
Greater vulnerability of unmyelinated axons to TBI has previously been described 
(Reeves et al., 2005; 2007) and may be due to greater exposure of the axolemma to 
post-traumatic processes.  In human mild TBI axonal damage has been suggested to 




The present study did not address the effects of mild TBI on the glial component of 
white matter.  Increased numbers of astrocytes have been observed to persist in white 
matter for as long as 16 weeks after mild TBI (Uryu et al., 2002) and microglial 
staining has been observed in the fimbria up to 1 week after mild TBI (Graham et al., 
2000).  Both these cell types may play a role, as elements of the inflammatory 
response to injury, in the development of pathology following mild TBI (Morganti-
Kossmann et al., 2007).  The effect of mild TBI on oligodendrocytes is unknown, 
although moderate injury in rats has been shown to induce apoptosis of 
oligodendrocytes which may impact on axonal survival following injury (Conti et al., 
1998). 
 
The limited amount of cell death observed and its presence in both sham and injured 
animals at all time points allows cell death to be excluded as a cause of cognitive 
changes in this study.  In the absence of lesions to grey matter structures, disruption 
of neural networks necessary for the water maze task may explain the cognitive 
deficits observed.  Damage in the dorsal thalamus is apparent at one week after the 
time point at which a learning deficit was observed.  Lesions of the thalamus have 
been demonstrated to impair acquisition of the water maze task, probably due to 
disruption of connections between the thalamus and hippocampus (Cain et al., 2006; 
Warburton and Aggleton, 1999; Warburton et al., 2001).  Damage observed in other 
regions may also play a role in the deficits observed.  The cingulum, in addition to its 
thalamic connections, contains projections to the hippocampus and has been 
implicated in spatial memory processes (Meunier and Destrade, 1988) and 
involvement of the external capsule in memory, due to the projections to the 
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amygdala that it contains has also been demonstrated (Lin et al., 2003).  Although 
neuronal damage is minimal, there may be other pathologies which have not been 
examined, contributing to the observed cognitive deficits, such as dendritic atrophy 
or synaptic loss. 
In cued platform testing in the water maze motor and visual impairments were ruled 
out as confounding variables by the equivalent performance of sham and injured 
animals.  In the hidden platform version of the task at 3 weeks after injury injured 
animals were unable to improve their performance over five days of training.  The 
performance of sham animals improved over the same period of time, so that they 
were able to find the platform significantly faster than injured animals on the final 
two days of training, indicating that injured animals were impaired in their ability to 
learn the location of the platform.  Injured animals were able to successfully recall 
the location of the platform as well as shams at both 10 minutes and 24 hours after 
training, showing that their short- and long-term memory was intact.  The inability of 
injured mice to improve their latency to find the platform over the training days, 
despite having intact memory for its location suggests that they may not have been 
using an optimal strategy to search for the platform.  Thalamic lesions have been 
demonstrated to produce deficiencies in search strategy learning in rats (Cain et al., 
2006; Warburton and Aggleton, 1999).  The absence of a learning or memory deficit 
at 6 weeks after injury does not necessarily indicate that cognitive deficits injured 
animals had resolved by this time point.  Prior testing in the water maze can result in 
savings in task acquisition that may persist for several months in mice and rats (Dellu 
et al., 1997; Pitsikas et al., 1991; Vicens et al., 2002).  This pretraining effect may 
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have been sufficient to overcome any cognitive changes persisting to 6 weeks in this 
model. 
 
The current study described a model of TBI in which specific and localised axonal 
damage in the absence of alterations in myelin is sufficient to produce an impairment 
in spatial learning that is detectable at 3 weeks after injury.  We have also 
documented an evolution in axonal pathology over time that occurs in white matter 
tracts that are implicated in cognition.  The association of axonal damage with 
cognitive deficits in this model suggests that preservation of axons following injury 




4 Effect of mild traumatic brain injury on white matter and 





Traumatic brain injury (TBI) is a major environmental risk factor for Alzheimer’s 
disease (AD) but relatively little is known about the underlying mechanisms.  This is 
in part due to the lack of models applying mild TBI to transgenic models of AD.  The 
previous chapter described the development of a mouse model of mild traumatic 
brain injury (TBI) which shows selective, progressive axonal damage.  This model of 
mild TBI can now be used to provide mechanistic insight to links between TBI and 
development of AD. 
 
A number of epidemiological studies have documented an increased risk of AD in 
individuals with a history of TBI (Guskiewicz et al., 2005; Johnson et al., 2010; 
Szczygielski et al., 2005).  In neuropathological studies, deposition of amyloid β 
(Aβ) and the occurrence of fibrillary inclusions of hyperphosphorylated tau in brain 
in injured brains indicate that AD-like pathology may develop in response to TBI.  In 
contrast to human studies of the effects of TBI and the development of AD-like 
pathology, studies in mouse models have produced equivocal results (Szczygielski et 
al., 2005), with some studies even reporting a decrease in amyloid pathology 
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following severe TBI (Nakagawa et al., 2000).  Imaging studies have suggested that 
white matter damage is another source of commonality between TBI and AD as both 
brain injured (Kraus et al., 2007) and AD (Targosz-Gajniak et al., 2009) patients 
show white matter damage associated with cognitive impairment. 
 
Transgenic animals are crucial for investigating links between mild TBI and AD as 
examination of this in humans is difficult due to the low proportion of individuals 
with mild TBI who present clinically and to the low mortality rates immediately 
following injury in this group (Bruns and Hauser, 2003).  Modelling mild TBI in 
transgenic models of AD in addition to enabling elucidation of possible mechanisms 
for the link between TBI and AD may also allow identification of pathological stages 
suitable for clinical intervention. 
 
4.1.1 Aims and hypotheses 
 
To investigate the effect of mild TBI on amyloid β, tau and white matter pathology in 
a transgenic mouse model of AD, axons, myelin, amyloid β and tau as well as the 
levels of axonal and AD-related proteins were examined at 24 hours after mild TBI. 
 
In a transgenic model of AD it was hypothesised that mild TBI would cause axonal 
damage as well as deposition of Aβ and in white matter in the hours after injury as 
well as increases in intracellular levels of Aβ and tau.  It was also predicted that 






4.2.1 Fluid percussion surgery and transgenic mice 
 
Twenty-eight 9 to 10 month old male triple transgenic (3xTg) mice weighing 27 – 
30g underwent mild lateral FPI (injury severity = 0.8 ± 0.1atm) or sham surgery as 
described in chapter 2.1.  Righting times for injured animals (167 ± 15 seconds) were 
significantly longer than for control animals (17 ± 6 seconds, p < 0.001).  Surgical 
procedures were carried out by Dr. Jill Fowler.  These animals were divided into two 
cohorts.  Cohort 1 was used for histological and immunohistochemical analyses and 
consisted of 6 sham and 8 injured animals.  Cohort 2 was used for biochemical 
analyses and comprised 7 sham and 7 injured animals. 
 
The 3xTg mice, as described by Oddo et al. (2003a; b), carry APPSwe, PS1M146V and 
tauP301L transgenes.  The APPSwe and PS1M146V are mutant human transgenes 
encoding amyloid precursor protein (APP) and presenilin 1, respectively.  Both of 
these mutations have been identified in familial Alzheimer’s disease and are 
associated with increased Aβ.  The tauP301L transgene harbours a mutation that causes 
neurofibrillary tangle formation in frontotemporal dementia with parkinsonism 
linked to chromosome 17 (FTDP-17).  These mice have been reported to develop 
age-related Aβ pathology from 3 months of age and tau pathology from 12 months 




4.2.2 Histology and immunohistochemistry 
 
Cohort 1 animals were sacrificed 24 hours after injury.  Animals were deeply 
anaesthetised and transcardially perfused with 20 ml heparinised 0.9% saline in 0.1% 
phosphate buffer followed by 4% paraformaldehyde in 0.1% phosphate buffer.  
Brains were postfixed and embedded in paraffin as described in chapter 2.4.  6 µm 
thick sections were cut and mounted in pairs on poly-L-lysine coated slides.  Slides 
containing sections from the level corresponding to -1.94mm from bregma according 
to Franklin and Paxinos were selected for staining with haematoxylin and eosin 
(H&E) and fluoro-jade C (FJC) to determine the presence of neuronal damage.  A 
section from a mouse that had undergone transient focal ischaemia for 1 hour with 23 
hours survival at the level corresponding to 0.50mm from bregma served as a 
positive control for FJC staining.  Sections adjacent to those used for histological 
staining were selected for immunohistochemical staining.  Immunohistochemistry for 
amyloid precursor protein (APP) was performed to detect axonal damage.  Aβ 
pathology was detected using an antibody recognising an epitope between amino 
acids 18-22 (clone 4G8).  Myelin damage was investigated using antibodies against 
myelin associated glycoprotein (MAG) and myelin basic protein (MBP).  Normal tau 
was detected using an antibody recognising an epitope between amino acids 159-163 
(clone HT7) and abnormally phosphorylated tau was detected with an antibody 
recognising tau phosphorylated at Ser202 (clone AT8)  The histological and 
immunohistochemical techniques used are described in detail in chapters 2.5 and 2.6.  
The methods used to quantify neuronal, axonal, myelin, amyloid and tau pathology 
are detailed in chapter 2.6.  Briefly, damage to neuronal perikarya was identified 
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using FJC or H&E stained sections in the cortex, hippocampus and dorsal thalamus.  
In H&E stained sections the presence or absence of damaged eosinophilic neurons 
was recorded.  In FJC stained sections the presence or absence of fluorescent, 
damaged neurons was noted.  APP stained sections were used to count axonal bulbs 
per mm
2
 in the cingulum, corpus callosum, cortex, external capsule, internal capsule 
and dorsal thalamus.  Counts of axonal bulbs in APP stained sections were log 
transformed for analysis.  In sections stained for Aβ darkly stained immunopositive 
bulbs were counted and analysed in the same way as in APP stained sections.  MBP 
stained sections were used to assess myelin integrity in the cingulum, corpus 
callosum, external capsule and internal capsule.  Relative optical density (ROD) 
measurements were used to quantify myelin integrity in these sections.  ROD values 
were averaged for each region and ipsilateral measurements expressed as a 
percentage of the corresponding contralateral measurement to control for possible 
differences in exposure time during staining.  Myelin debris in MAG stained sections 
was recorded as present or absent as was the presence of abnormal tau staining 
detected using AT8 and HT7 in the corpus callosum, cingulum, external capsule and 
internal capsule.  In 4G8 and HT7 stained sections intracellular staining was also 
assessed in the amygdala, cortex and CA1, CA2, CA3 and dentate gyrus subfields of 
the hippocampus using image analysis.  The regions of interest were photographed 
and the percentage surface area stained in each region photographed was measured in 
ImageJ (U. S. National Institutes of Health, Bethesda, USA).  The values obtained 




4.2.3 Western blotting 
 
Cohort 2 animals were terminated by cervical dislocation 24 hours after injury.  The 
brains were removed and homogenised in tissue homogenisation buffer and 
diethylamine buffer as described in chapter 2.7.  Western blotting was performed to 
detect APP, APP C-terminal fragments, normal human tau and abnormally 
phosphorylated tau.  Oligomeric Aβ was detected by dot blot.  Both Western blotting 
and dot blot procedures are detailed in chapter 2.8.  The intensity of fluorescence of 
the bands or dots was detected using Odyssey application software (version 3.0; Li-
Cor, Cambridge, UK). 
 
4.2.4 Statistical analysis 
 
Data from axonal counts in APP and 4G8 stained sections as well as and MBP, 4G8 
and HT7 image analysis were analysed using unpaired t-tests.  Western blot and dot 






4.3.1 Early accumulation of APP and Aβ in white matter after mild traumatic brain 
injury 
 
Injured animals had evidence of axonal damage in white matter tracts close to the 
injury site.  Aβ staining was also present in the same white matter regions in injured 
animals.  There were significantly higher levels of axonal damage in the ipsilateral 
cingulum and external capsule of injured animals (|t| = 3.483, p = 0.022 and |t| = 
6.233, p < 0.001, respectively; Figure 4.1B).  There were no significant differences 
between the groups in these regions in the contralateral hemisphere (|t| = 0.153, p = 
0.881, cingulum; |t| = 1.000, p = 0.363, external capsule; Appendix B.1).  There were 
no differences between sham and injured animals in the corpus callosum (|t| = 0.857, 
p = 0.408, ipsilateral; |t| = 0.204, p = 0.841, contralateral; Appendix B.2), cortex (|t| = 
1.908, p = 0.098, ipsilateral; no damage observed in either group contralaterally; 
Appendix B.2), internal capsule (|t| = 1.572, p = 0.177, ipsilateral; |t| = 0.081, p = 
0.937, contralateral; Appendix B.2) and thalamus (|t| = 0.222, p = 0.828, ipsilateral; 
|t| = 886, p = 0.393, contralateral; Appendix B.2). 
 
Injured animals had more Aβ accumulations than shams the same regions that 
showed axonal damage in APP immunostaining.  There was significantly more Aβ 
accumulation in the ipsilateral cingulum and external capsule of injured animals 
compared to shams (|t| = 5.494, p < 0.001 and |t| = 13.413, p < 0.001, respectively; 
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Figure 4.1B).  No difference was observed between the groups in these regions in the 
opposite hemisphere (|t| = 0.350, p = 0.732, cingulum; |t| = 0.476, p = 0.643, external 
capsule; Appendix B.1).  Injured animals did not show more evidence of Aβ staining 
in the corpus callosum (|t| = 0.857, p = 0.408, ipsilateral; no damage observed in 
either group contralaterally; Appendix B.2), cortex (|t| = 1.480, p = 0.183, ipsilateral; 
no damage observed in either group contralaterally; Appendix B.2), internal capsule 
(|t| = 0.152, p = 0.172, ipsilateral; no damage observed in either group 
contralaterally; Appendix B.2) and thalamus (|t| = 1.474, p = 0.173, ipsilateral; |t| = 






Figure 4.1: Accumulation of APP and Aβ in white matter in the same regions after mild TBI 
Following mild TBI APP and Aβ were found to be accumulated in white matter in the cingulum and external capsule.  
Representative staining from the external capsule taken at 40x magnification is shown.  Blue arrowheads on APP stained 
sections indicate accumulations of APP and blue arrows on Aβ stained sections indicate accumulations of Aβ (A).  The 
difference between the groups in the number of accumulations counted was significant in the ipsilateral external capsule and 
cingulum but not in the same regions contralaterally (B; line represents mean).
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4.3.2 No tau changes in white matter after mild traumatic brain injury 
 
In sections stained for both total and hyperphosphorylated tau there was no evidence 
of staining in the corpus callosum, cingulum, external capsule or internal capsule in 
any animal from any group.  No accumulations of normal or hyperphosphorylated 
tau were observed in any of the regions examined.  Figure 4.2 shows representative 





Figure 4.2: No abnormal tau staining was observed following injury 
Examination of white matter regions in sections stained for both 
hyperphosphorylated and total tau showed no abnormal staining after injury.  
Representative images from the ipsilateral external capsule at 40x  




4.3.3 No change in intraneuronal amyloid after mild traumatic brain injury 
 
There was no significant difference between the groups in the level of intraneuronal 
Aβ in any region examined.  Injured and sham animals showed the same level of Aβ 
staining in all regions examined ipsilaterally including the amygdala (|t| = 0.482, p = 
0.639; Appendix B.4), cortex (|t| = 0.220, p = 0.829; Appendix B.4) and hippocampal 
subfields: CA1 (|t| = 0.940, p = 0.366; Figure 4.3B), CA2 (|t| = 0.515, p = 0.616; 
Appendix B.4), CA3 (|t| = 0.523, p = 0.610; Appendix B.4) and dentate gyrus (|t| = 
1.047, p = 0.316; Appendix B.4).  Staining was also unaltered in injured animals in 
the contralateral hemisphere (|t| = 0.345, p = 0.736, amygdala; |t| = 0.705, p = 0.495, 
cortex; |t| = 1.028, p = 0.324, CA1; |t| = 0.335, p = 0.743, CA2; |t| = 0.198, p = 0.846, 





Figure 4.3: Mild TBI does not produce changes in intracellular Aβ or tau staining 
Examination of the percentage area stained revealed no differences in intracellular Aβ or tau following mild FPI.  
Representative images taken at 10x magnification of staining in the CA1 region of the ipsilateral hippocampus are shown (A).  
The percentage area stained was not affect by injury (B; line represents mean value). 
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4.3.4 No change in intraneuronal tau after mild traumatic brain injury 
 
There was no significant difference between the groups in the level of tau in any 
region examined.  Staining for normal tau also did not reveal any differences 
between the groups in the amygdala (|t| = 0.130, p = 0.899; Appendix B.5), cortex (|t| 
= 0.683, p = 0.508; Appendix B.5), CA1 (|t| = 0.488, p = 0.634; Figure 4.3B), CA2 
(|t| = 1.976, p = 0.092; Appendix B.5), CA3 (|t| = 0.250, p = 0.807; Appendix B.5) 
and dentate gyrus (|t| = 0.482, p = 0.639; Appendix B.5) ipsilaterally.  Injured and 
sham animals also did not differ in the same regions in the contralateral hemisphere 
(|t| = 0.319, p = 0.755, amygdala; |t| = 0.529, p = 0.606, cortex; |t| = 0.569, p = 0.580, 
CA1; |t| = 0.482, p = 0.639, CA2; |t| = 0.179, p = 0.861, CA3; |t| = 0.916, p = 0.378, 
dentate gyrus; Appendix B.5). 
 
4.3.5 Mild traumatic brain injury does not increase cell death 
 
Neither H&E nor FJC staining showed evidence of elevated levels of cell death in 
injured animals.  In H&E stained sections cell death was confined to the cortex local 
to the injury site and isolated damaged neurons in the ipsilateral hippocampus 
(Figure 4.4).  Five injured animals out of 8 showed evidence of cell death in the 
cortex as did 3 sham animals out of 6.  In the ipsilateral hippocampus 3 injured and 1 
sham animal had single ischaemic neurons present.  One further injured animal had 
numerous ischaemic cells throughout the hippocampus.  There was no evidence of 
 
 106 
cell death in the contralateral cortex or hippocampus or bilateral amygdala or 
thalamus of any animal. 
 
In FJC stained sections a similar pattern of staining was observed with 6 injured and 
4 sham animals showing positive cells in the ipsilateral cortex (Figure 4.4).  Three 
injured animals also had single positive cells in the ipsilateral hippocampus and 
another showed evidence of more extensive hippocampal cell death.  No cell death 






Figure 4.4: Sham and injured animals show comparable levels of cell  
death after mild TBI 
Cell death following surgery was evident in both sham and injured animals.  
Cell death was visible in the cortex close to the injury site and levels were 
comparable in the two groups.  Images are representative of H&E staining 
and FJC staining in the ipsilateral cortex and taken at 20x magnification.  




4.3.6 No evidence of myelin damage following mild traumatic brain injury 
 
Neither of the two markers used to assess myelin damage showed evidence of 
alterations after mild TBI.  In MBP stained sections, relative optical density of 
staining in ipsilateral regions expressed as a percentage of control was unaltered: (|t| 
= 1.087, p = 0.298, cingulum; |t| = 0.775, p = 0.454, corpus callosum; |t| = 1.922, p = 
0.079, external capsule; |t| = 0.389, p = 0.704, internal capsule; Appendix B.3). 
 
In MAG immunostained sections 2 injured and 2 sham animals had evidence of 
minimal myelin debris in the ipsilateral cingulum.  The 2 injured animals with 
ipsilateral cingulum damage also showed minor amounts of debris in the 
contralateral cingulum, while one sham animal also had evidence of myelin debris in 
the contralateral hemisphere.  A single injured and 1 sham animal showed small 
amounts of myelin debris in the ipsilateral internal capsule and low levels of myelin 
debris were visible in the contralateral internal capsule of 2 injured animals.  There 
was no evidence of myelin debris in any animal in the external capsule or corpus 
callosum. 
 
4.3.7 No change in levels of APP and related proteins after mild traumatic brain 
injury 
 
There were no changes detected in the levels of APP related proteins investigated 
following mild TBI.  Levels of APP, C-terminal fragments and oligomeric Aβ were 
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unaltered in injured animals compared to shams.  Western blotting for APP showed a 
double band at 100kDa.  No difference in the amount of APP was detected between 
injured or sham animals in the ipsilateral (|t| = 0.273, p = 0.790) or contralateral (|t| = 
1.448, p = 0.173; Figure 4.5A) hemispheres.  The C99 C-terminal fragment that is 
formed by the amyloidogenic processing pathway produced a band at 9kDa, was not 
altered in the ipsilateral (|t| = 1.052, p = 0.313) or contralateral (|t| = 2.147, p = 0.064; 
Figure 4.6) hemispheres.  Dot blots for oligomeric Aβ revealed no differences 
between sham and injured animals (|t| = 1.246, p = 0.236, ipsilateral; |t| = 1.545, p = 
0.148, contralateral; Figure 4.5B).  The C-terminal fragment, C83, formed by the 
non-amyloidogenic processing pathway produced a band at 11kDa and was also 
unchanged in both the ipsilateral (|t| = 1.309, p = 0.215) and contralateral (|t| = 1.945, 
p = 0.076; Figure 4.6).  The ratio between the two C-terminal fragments was also 
unchanged in injured animals (|t| = 0.544, p = 0.597, ipsilateral; |t| = 1.011, p = 0.332, 






Figure 4.5: Levels of APP and oligomeric Aβ are unaltered at 24 hours  
after mild TBI 
Levels of APP and oligomeric Aβ were unaltered 24 hours after mild TBI.  
Western blotting for APP showed a double band at 100kDa (A).  Levels in 
injured animals were unaltered compared to shams in both hemispheres.  
Dot blot analysis of oligomeric Aβ levels showed no differences between 





Figure 4.6: Levels of C-terminal fragments are unaltered at 24 hours 
after mild TBI 
Levels C-terminal fragments were unaltered 24 hours after mild TBI.  In 
Western blots for C-terminal fragments the C99 fragment generated by 
amyloidogenic cleavage of APP was visible at 9kDa while the non 
amyloidogenic fragment was present at 11kDa.  Injured animals did not differ 
from shams in levels of either fragment or in the ratio of the two  





4.3.8 No change in levels of tau protein after mild traumatic brain injury 
 
There were no changes detected in the levels of tau protein after mild TBI.  Levels of 
normal tau detected using the HT7 antibody were unaffected by mild FPI.  (|t| = 
0.582, p = 0.571, ipsilateral; |t| = 0.433, p = 0.673, contralateral; Figure 4.7A)  No 
abnormally phosphorylated tau band was detected using AT8 antibody and analysis 
of normal tau detected using this antibody showed unchanged levels in injured 
compared to sham animals (|t| = 0.209, p = 0.838, ipsilateral; |t| = 0.484, p = 0.643, 





Figure 4.7: Levels of tau are unaltered at 24 hours after mild TBI 
Levels of normal and total tau were unaltered 24 hours after mild TBI.  
Western blotting for total tau showed no changes in injured animals 
compared to shams in either hemisphere (A).  Use of the AT8 antibody for 
hyperphosphorylated tau did not show a band of hyperphosphorylated tau 
but did show a normal tau band at 54kDa (B).  Normal tau levels were no 
different in sham and injured animals in either hemisphere.  Graphs show  






TBI is the major environmental risk factor for AD.  AD-like pathological changes are 
well documented in humans following moderate and severe TBI but the mechanism 
of the link between the two is unknown.  This study examined the effect of mild TBI 
on axons, myelin, amyloid β and tau as well as the levels of axonal and AD-related 
proteins.  The hypothesis that mild TBI would cause axonal damage as well as 
deposition of Aβ in white matter was upheld with the observation of accumulations 
of Aβ and APP staining in white matter regions.  The hypothesised increase in 
intracellular levels of Aβ and tau was not observed as no difference in intracellular 
Aβ or tau staining was observed between injured and sham animals.  It had also been 
hypothesised that overall levels of APP, Aβ and normal and hyperphosphorylated tau 
would be increased, however these levels of these proteins were not found to be 
altered in injured animals compared to sham controls. 
 
In injured animals, Aβ staining was observed in white matter tracts that also 
displayed axonal damage, as measured by APP staining, in areas close to the injury 
site.  Co-accumulation of APP, Aβ and other components of the APP cleavage 
pathway has been found in axons in human brains following TBI (Chen et al., 2009; 
Uryu et al., 2007) and similar findings have been made in pigs in a TBI model 
designed to produce axonal pathology (Chen et al., 2004; Smith et al., 1999) and in 
rats after moderate TBI (Iwata et al., 2002).  Accumulated APP in axons after TBI 
has been proposed as a substrate for increased Aβ production after injury (Johnson et 
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al., 2010; Szczygielski et al., 2005).  The axonal location of APP cleavage to Aβ is 
unknown.  Experiments showing that APP, β-secretase and presenilin are transported 
along the axon together and that APP may be cleaved to Aβ during transport (Kamal 
et al., 2001) have been contradicted by later reports (Lazarov et al., 2005).  An 
alternative axonal location for cleavage of APP to Aβ is lipid rafts, assemblies of 
cholesterol and sphingolipids located in the external layer of the plasma membrane.  
The axonal membrane is enriched in lipid rafts (Simons and Toomre, 2000) and APP 
has been shown to be present in lipid rafts (Taylor and Hooper, 2007) which have 
been suggested as necessary for β-secretase cleavage of APP (Ehehalt et al., 2003).  
Although the location of APP processing following TBI is unclear it is known that 
both β- and γ-secretase activity is upregulated by oxidative stress (Tamagno et al., 
2005; 2008).  Therefore increases in oxidative stress following TBI may be 
responsible for enhanced production of Aβ from accumulated APP.  The present 
study did not demonstrate co-accumulation of APP and Aβ, however, nor did it 
confirm that the observed Aβ accumulated in axons.  Confirmation of both these 
points could be achieved in a multi-labelling immunohistochemistry study to 
investigate whether APP and Aβ staining co-localises and whether Aβ is 
accumulated in neurofilament positive axons. 
 
Axonal damage has been identified as an early pathological event in a transgenic 
mouse models of AD as well as in human AD (Stokin et al., 2005).  If axonal 
pathology is a precipitating factor for other aspects of AD pathology under non 
injury conditions this suggests that damage to axons would accelerate the 
development of AD pathology.  Stokin et al. (2005) and Johnson et al. (2010) 
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propose that accumulated Aβ in axons may be released by lysis of degenerating 
injured axons, leading to the extracellular pathology that is considered definitive of 
AD.  This is supported by the observation of Aβ plaques in white matter close to 
damaged axons in individuals who died days after TBI (Smith et al., 2003b).  Aβ 
accumulations in white matter have been found to persist for up to 6 months 
following injury in a pig model (Chen et al., 2004), and 1 year in a rat model (Iwata 
et al., 2002), providing a potential long-term pool of Aβ.  In addition to axonal 
damage caused by TBI, intra- and extracellular Aβ are capable of impairing axonal 
transport (Muresan and Muresan, 2006; Pigino et al., 2009) and may contribute to 
further development of axonal pathology after TBI.  The appearance of Aβ 
accumulations 24 hours after injury in this study indicates that early intervention 
after injury may have a role in preventing long-term accumulation of Aβ.  Assessing 
the efficacy of such an intervention first requires assessment of the development of 
pathology in this model over the weeks following injury.  Examination of longer 
term survival after injury will indicate whether the regional distribution of Aβ 
accumulations changes over time after injury, as observed with APP accumulation in 
the previous chapter. 
 
The use of transgenic models of AD pathology in TBI research has focused on 
plaque pathology as a clear indicator of pathological similarities to both AD in 
humans and studies demonstrating extracellular deposition of Aβ after injury 
(Ikonomovic et al., 2004; Smith et al., 2003c).  However, in contrast to studies in 
humans the effects of TBI on Aβ deposition in transgenic mouse models have given 
somewhat mixed results.  In fact, severe TBI in aged PDAPP mice has been shown to 
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induce reductions in Aβ deposition at 9 and 16 weeks after injury as well as reducing 
the amount of Aβ deposited over time following injury in young mice (Nakagawa et 
al., 1999; 2000).  In these studies a severe injury level was used, resulting in massive 
loss of hippocampal neurons and reducing the potential pool of Aβ producing cells 
which may explain these anomalous findings.  However, mild TBI, without cell loss 
has been shown to produce an increase in Aβ deposition at the same time points 
(Uryu et al., 2002).  In the current study no plaque pathology was observed, however 
the time point observed here encompassed only the most acute events after injury, in 
the interests of observing early changes in AD-type pathology that may be suitable 
for therapeutic intervention. 
 
No changes were observed in the amount of intracellular Aβ staining observed after 
injury in this study.  Given that this model of TBI did not produce any other cellular 
changes this is not surprising.  Increases in intracellular Aβ have been reported 
following TBI in rats (Hoshino et al., 1998; Iwata et al., 2002) or in mice with a 
human familial AD APP mutation knocked into murine APP (Abrahamson et al., 
2006).  In all these studies there was also significant neuronal loss following injury, 
owing to the greater injury magnitudes used. 
 
The absence of abnormalities in tau staining in both grey and white matter are likely 
a reflection of the temporal order in which AD pathology progresses, with 
accumulation of Aβ appearing prior to neurofibrillary tau tangles.  It may be that 
mild TBI is not in itself sufficient to induce changes in tau but tau pathology may 
occur downstream of TBI-induced Aβ pathology.  In the mouse model used in the 
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study described here it has previously been shown that vaccination against Aβ 
cleared extracellular and intracellular Aβ as well as deposits of tau (Oddo et al., 
2004).  Tau pathology reemerged only after the reappearance of Aβ deposits, 
indicating that in this transgenic model the development of tau pathology is 
dependent on the presence of Aβ pathology.  Furthermore, in the case of dementia 
pugilistica, a dementia whose primary pathology is deposition of neurofibrillary 
tangles, patients are typically boxers, who suffer repeated injuries over the course of 
their careers (Marklund et al., 2009; Toth et al., 2005) rather than in individuals who 
have suffered a single TBI, suggesting that a single incident of mild TBI may not be 
sufficient to induce neurofibrillary tangles. 
 
Overall, levels of proteins relevant to amyloid pathology in AD; APP, oligomeric Aβ 
and C-terminal fragments as well as levels of tau protein were unaltered following 
mild TBI.  Hyperphosphorylated tau was not detected by Western blot in any animal.  
This is not necessarily a finding inconsistent with the results of the pathological 
investigation.  Accumulation of APP and Aβ was confined to a small anatomical 
region in immunohistochemical analysis and these changes may have been too small 
to be detectable in tissue samples incorporating a relatively larger amount of tissue 
from unaffected regions.  Examination of protein levels specifically in damaged 
white matter has demonstrated elevations in APP and the amyloidogenic C99 C-
terminal fragment in a model of diffuse axonal injury (Chen et al., 2004).  Aβ levels 
in PDAPP mice are also known to increase sharply after injury, peaking at 2 hours 
before declining again over the following hours (Smith et al., 1998).  Human 
investigations of Aβ levels in the acute period after injury have relied on 
 
 119 
measurements of Aβ in cerebrospinal fluid or dialysate and have returned mixed 
results in terms of temporal changes in Aβ levels.  In general the results suggest that 
there is a short term increase in Aβ levels followed by a decrease (Brody et al., 2008; 
Franz et al., 2003; Marklund et al., 2009; Raby et al., 1998).  Analysis of dialysate 
from the brains of patients with diffuse axonal damage showed lower levels of tau 
than in a group with focal damage (Marklund et al., 2009), although the implications 
of this in the absence of an appropriate control population are unclear. 
 
This chapter describes the effects of mild TBI in a transgenic model of AD.  The 
model shows accumulation of Aβ associated with axonal damage at 24 hours after 
injury.  We have determined that intracellular Aβ and tau in both grey and white 
matter are unaffected at this time point.  Accumulation of Aβ in white matter regions 
that also show axonal damage shows a role for axonal damage in mediating the link 
between TBI and AD.  Additionally, the accumulation of Aβ at 24 hours after injury 
demonstrates that AD-related pathological changes occur soon after injury, implying 





5 Effect of chronic cerebral hypoperfusion on white matter 




Chronic cerebral hypoperfusion has been associated with poor performance in 
cognitive testing in adults over 55 years old (Appelman et al., 2010; Ruitenberg et 
al., 2005; Tiehuis et al., 2008).  It has been suggested that this effect is mediated by 
white matter damage (Pantoni and Garcia, 1997) and white matter changes have been 
correlated with deficits in executive function, processing speed and episodic memory 
in aging populations (Bucur et al., 2008; Deary et al., 2003; Delano-Wood et al., 
2009; Kennedy and Raz, 2009; Vernooij et al., 2009).  Additionally, changes in 
white matter in aging populations have been associated with changes in cerebral 
blood flow (CBF) in cross-sectional (Bisschops et al., 2004; Vernooij et al., 2008) 
and post-mortem studies (Fernando et al., 2006). 
 
The difficulty in establishing a causal relationship in studies with a correlational 
design and in populations where pathologies other than hypoperfusion may confound 
the results has necessitated the development of animal models of chronic cerebral 
hypoperfusion.  In rats this is achieved by permanent occlusion of both common 
carotid arteries and produces a model with a combination of neuronal cell body 
damage and white matter damage (Farkas et al., 2007 for review).  Although deficits 
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in performance have been observed in both the water maze (Farkas et al., 2004b; 
Pappas et al., 1996) and radial arm maze (Murakami et al., 2000; Pappas et al., 1996) 
up to 5 months after in induction of hypoperfusion; the presence of variable levels of 
neuronal damage in this model makes interpretation of these findings with regard to 
white matter changes difficult 
 
More recently, a mouse model of chronic cerebral hypoperfusion was developed 
involving permanent narrowing of the common carotid arteries by application of 
microcoils (Shibata et al., 2004).  This resulted in diffuse, selective damage to white 
matter, visible after 14 days of hypoperfusion.  Behavioural analysis conducted in a 
separate cohort of animals found a deficit in working memory after 2 months of 
hypoperfusion without deficits in spatial reference memory or contextual and cued 
fear conditioning (Shibata et al., 2007).  The absence of parallel behavioural and 
pathological analysis in the same animals and additionally the relative novelty of the 
model means that there is room for investigation of the robustness of these findings 
and examination of further aspects of cognitive function relevant to human cognitive 
decline linked to white matter damage and cerebral hypoperfusion. 
 
5.1.1 Aims and hypotheses 
 
To investigate the effects of chronic cerebral hypoperfusion on cognition and white 
matter pathology in wild-type mice, axonal and myelin damage as well as a number 




Chronic cerebral hypoperfusion was hypothesised to cause damage to elements of 








5.2.1 Induction of chronic cerebral hypoperfusion and animals 
 
3-4 month old male C57Bl6/J mice (Charles River, UK) weighing 25 – 30g 
underwent bilateral common carotid artery stenosis or sham surgery as described in 
chapter 2.1.  Surgical procedures were carried out by Dr. Karen Horsburgh.  Prior to 
behavioural testing animals were handled for 5 minutes per day for 5 consecutive 
days to minimise stress resulting from handling.  Separate cohorts of animals were 
used for each behavioural test. 
 
5.2.2 Testing of spatial reference learning and memory 
 
Water maze testing was carried out according to the protocol detailed in chapter 2.2.  
A day of pretraining on the cued version of the water maze task was carried out 
before surgery to exclude animals showing an abnormal stress response.  No animals 
were excluded on this basis from this study.  Five days of training on the cued 
version of the water maze task were carried out, beginning 2 weeks after surgery.  
Each animal received 4 training trials per day, with a 20 minute interval between 
trials.  Spatial reference memory training began 3 days after the end of training in the 
cued version of the task and continued for 5 days with 4 trials per day and a 10 
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minute intertrial interval.  Probe tests were carried out 10 minutes and 24 hours after 
the final trial of spatial reference training. 
 
5.2.3 Testing of episodic memory 
 
Animals were trained for one day before surgery on the cued version of the water 
maze task to exclude animals showing an abnormal stress response.  No animals 
were excluded on this basis from this study.  Four days of training on the cued 
version of the water maze task were carried out, beginning 2 weeks after surgery.  
Episodic memory was tested using a trials to criterion protocol as described by Chen 
et al. (2000).  The protocol used is described in detail in chapter 2.2.  Briefly, testing 
was as per the spatial reference memory procedure described above, with the 
following modifications: training on a task was stopped when the animal reached a 
criterion of an average of less than 20 seconds to the platform on 3 consecutive trials, 
the maximum number of trials permitted per day was 8 and once the performance 
criterion was reached or the animal reached 32 trials (except on task 1 where the 
maximum number of trials permitted was 40), training was stopped and training on a 
new platform location begun on the following day.  This was carried out for a 
minimum of 10 training days or until 5 platform locations had been learned.  
Retention was probed as described above at 10 minutes and again at 3 hours after 




5.2.4 Testing of working memory 
 
Working memory was tested in an 8-arm radial maze (Olton and Samuelson, 1976) 
using a protocol adapted from Shibata et al. (2007).  Animals were food deprived to 
between 85 and 90% of initial body weight beginning 4 weeks after surgery.  Pre-
training to acclimatise animals to the maze environment and to allow them to learn to 
retrieve food pellets from the food wells began 3 weeks after surgery.  After 2 days 
of pre-training training on the working memory task began.  All 8 arms of the maze 
were baited with food pellets during training trials.  At the start of a trial the animal 
was placed in the centre of the maze and allowed to choose an arm.  When the 
animal returned to the centre of the maze they were confined there for 5 seconds 
before being allowed to make another arm choice.  A re-entry into a previously 
visited arm counted as an error.  Each trial lasted until the animal had retrieved all 8 
food pellets or 25 minutes had elapsed.  Each animal completed one trial per day of 
training.  After 16 days an extra 2 minute confinement in the centre of the maze was 
introduced after the animal had made 4 arm choices.  Further details of this protocol 
can be found in chapter 2.2. 
 
Two cohorts of animals were tested in this task, owing to the high proportion of 
hypoperfused mice showing ischaemic neuronal damage in the first cohort.  This left 
group numbers too low for reliable statistical analysis.  The second cohort of animals 
was tested in the radial arm maze 11 months after the first by Ms. Jess Smith, Dr. 




5.2.5 Pathological assessment 
 
The histological and immunohistochemical staining described in this chapter was 
carried out by Mrs. Fiona Scott and Mr. Tommy Dingwall while all analysis with the 
exception of degraded myelin was carried out by Mr. Robin Coltman.  Sections 
stained for degraded myelin were assessed by Dr. Horsburgh.  Perfusions were 
carried out by Mr. Coltman, Ms. Smith and Ms. Tsenkina.  Mice that underwent 
spatial reference training were perfused at one month after surgery.  Mice that had 
undergone episodic memory and working memory testing were perfused at two 
months after surgery. 
 
For assessment of ischaemic damage to neuronal cell bodies sections were stained 
using haematoxylin and eosin (H&E) as described in chapter 2.5.  Sections were 
immunostained as described in Chapter 2.6 with antibodies against myelin associated 
glycoprotein (MAG; 1:500 dilution, Santa Cruz), amyloid precursor protein (APP; 
1:1000 dilution, Millipore), degraded myelin basic protein (dMBP; 1:300 dilution, 
Millipore) and anti-ionised calcium-binding adaptor molecule, a marker of activated 
microglia (Iba-1; 1:750 dilution; Biocare Medical).   
 
Ischaemic damage to neuronal cell bodies was assessed as being present or absent 
throughout the brain.  Immunohistochemical staining was analysed in the corpus 
callosum, external capsule, internal capsule, fimbria, optic tract and fibre bundles of 
the caudate (Figure 5.4K).  Immunostaining against MAG showed myelin damage, 
defined as disorganisation and vacuolation of white matter fibres and the presence of 
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debris.  This was graded on a 4 point scale from normal (grade 0), through minimal 
(grade 1), modest (grade 2) and extensive (grade 3).  dMBP immunostaining 
revealed degraded myelin which was also graded on a 4 point scale; beginning with 
normal staining (grade 0), minimal areas of degraded myelin (grade 1), moderate 
areas of degraded myelin (grade 2) and extensive areas of degraded myelin (grade 3).  
Axonal damage was identified by APP staining of swollen or bulbous axons and 
graded as normal (grade 0), minimal (grade 1); moderate (grade 2) and extensive 
(grade 3).  Grades for each region were assigned to both hemisphere  Activated 
microglia were counted in a grid of defined size in random fields within each region 
examined and the number of Iba-1 positive cells per square millimetre calculated.  
Cell counts were averaged across hemispheres. 
 
5.2.5 Statistical analysis 
 
Data from the water maze and radial arm maze studies were analysed using two-way 
ANOVA, using the Greenhouse-Geiser correction where data were significantly non-
normal (i.e. where Mauchly’s test returned a value of p < 0.05).  Radial arm maze 
data were analysed across blocks of two averaged training days.  Post hoc 
comparisons were made using unpaired t-test.  Swim speeds from cued water maze 
testing and the number of tasks learned in the episodic memory task were analysed 
using unpaired t-test.  Graded scores obtained from pathological analysis were 
summed and analysed using Fisher’s exact test.  The numbers of activated microglia 






5.3.1 Diffuse white matter damage after chronic cerebral hypoperfusion  
 
A minority of hypoperfused animals showed evidence of ischaemic neuronal 
damage.  These animals were excluded from all pathological and behavioural 
analyses.  The numbers of animals excluded from each cohort are detailed below.  
Analysis of MAG staining showed widespread myelin damage in hypoperfused 
animals after both 1 and 2 months of hypoperfusion (Figure 5.1C, D; Figure 5.2).  
Levels of degraded myelin as identified using dMBP staining were increased in 
hypoperfused animals at both one and two months after induction of hypoperfusion 
(Figure 5.1E, F; Figure 5.2).  Axonal damage was observed in some hypoperfused 
animals at both time points but not in shams (Figure 5.1G, H; Figure 5.2).  
Hypoperfused animals also displayed elevated microglial activation compared to 






Number of mice 
excluded 
Reason Final numbers 
Spatial reference 




9 sham, 9 
hypoperfused 
 





Episodic memory 4 hypoperfused 
Ischaemic 
neuronal damage 
11 sham, 10 
hypoperfused 
 










10 sham, 3 
hypoperfused 





17 sham, 7 
hypoperfused 
 
Table 5.1: Numbers of animals excluded from behavioural analyses 
Summary of the numbers of animals excluded from each behavioural  







Figure 5.1: Representative images of pathology after one month of hypoperfusion in mice 
Images show pathology in sham and hypoperfused animals 1 month after the induction of hypoperfusion.  Neuronal cell bodies 
in the hippocampal CA1 were intact (A, B).  Hypoperfused animals showed a loss of myelin integrity in the optic tract (C, D).  
Hypoperfused animals also displayed myelin debris in the optic tract (E, F).  Damaged axons were visible in the optic tract of 
some hypoperfused animals (G, H).  Microglial activation was also evident in the optic tract of hypoperfused animals (I, J). 







Figure 5.2: Analysis of pathology after one and two months of hypoperfusion in mice 
Scores for pathology in each region examined were summed to give total scores for analysis.  There was a significant loss of 
myelin integrity, identified using MAG immunostaining in hypoperfused animals at both 1 and 2 months of hypoperfusion.  The 
amount of degraded myelin, identified using dMBP immunostaining was significantly increased in hypoperfused animals at 
both 1 and 2 months after the induction of hypoperfusion.  There was evidence of axonal damage in hypoperfused animals 
and this was significantly different from shams after 2 months of hypoperfusion.  Hypoperfused animals also showed elevated 
microglial activation, which was significantly different to shams after 2 months of hypoperfusion.  Line in microglial activation 
graph represents the mean value; in all other graphs line represents the median value.  Representative graphs of pathological 
data for 2 months of hypoperfusion show data from animals that underwent episodic memory testing.  * = p ≤ 0.05 vs. sham. 




5.3.2 No impairment of spatial reference learning or memory following chronic 
cerebral hypoperfusion 
 
Animals showing persistent floating behaviour throughout the testing were excluded 
from the final analysis (n = 3 sham, 1 hypoperfused).  Animals which showed 
evidence of ischaemic neuronal damage were also excluded from the behavioural 
analysis (n = 2 hypoperfused).  This meant that the final numbers for analysis were n 
= 9 sham and n = 9 hypoperfused. 
 
Both injured and sham animals decreased their latency to the cued platform over the 
training period (F(1.317,21.072) = 21.961, p < 0.001; Figure 5.3A).  There was no 
difference in performance between the injured and the sham-operated groups (F(1,16) 
= 0.002, p = 0.969).  Escape latencies averaged less than 10 seconds in both groups 
by the end of training.  Mean swim speed across all trials did not differ significantly 
between injured and sham-operated animals (26.408 ± 0.974 cm/s vs. 26.440 ± 0.933 
cm/s; |t| = 0.024, df = 16, p = 0.981 respectively, mean ± SEM). 
 
In the spatial reference learning version of the water maze task both groups were able 
to learn the location of a hidden platform over the 5 training days (F(4,64) = 10.327, p 
< 0.001; Figure 5.3B).  There was no significant difference between the groups in 
their ability to learn the platform location (F(1,16) = 0.206, p = 0.656).  Both groups 
showed the same degree of preference for the training quadrant when probed both 10 
minutes (group x quadrant interaction, F(3,48) = 0.088, p = 0.966; Figure 5.3C) and 24 
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hours (group x quadrant interaction, F(2.099,33.591) = 0.664, p = 0.578; Figure 5.3D) 





Figure 5.3: Results of testing in the spatial reference memory task in 
the Morris water maze 
No difference between the groups was seen in any aspect of spatial 
reference memory testing (A – D).  Animals performed equally well in the 
cued version of the task (A), in the hidden platform version of the task (B) 
and in the probes at 10 minutes (C) and 24 hours (D).  Graphs show mean + 




5.3.3 No impairment of episodic memory following chronic cerebral hypoperfusion 
 
Animals showing persistent floating behaviour throughout the testing were excluded 
from the final analysis (n = 1 sham, 1 hypoperfused).  Animals which showed 
evidence of ischaemic neuronal damage were also excluded from the behavioural 
analysis (n = 4 hypoperfused).  This meant that the final group numbers for analysis 
were n = 11 sham and n = 10 hypoperfused. 
 
In pre-training on the cued version of the water maze task there was no difference in 
average swim speed between the two groups (25.254 ± 1.042 cm/s vs. 26.440 ± 
0.763 cm/s; |t| = 0.902, df = 19, p = 0.379 sham vs. hypoperfused, mean ± SEM).  
Both sham and hypoperfused animals successfully learned to swim to the visible 
platform over the 5 training days (F(1.768,33.600) = 34.538, p < 0.001; Figure 5.4A).  
The groups did not differ in their ability to learn this task (F(1,19) = 0.054, p = 0.818). 
 
The number of tasks animals required to learn the platform location to criterion did 
not change over the first 5 platform locations (F(4,76) = 1.566, p = 0.192; Figure 
5.4B).  Hypoperfusion did not affect the number of tasks required to learn the first 5 
platform locations to criterion (F(1,19) = 0.035, p = 0.853).  Analysis of the time spent 
in the training quadrant during probe testing across the first 5 platform locations 
revealed no difference between sham and hypoperfused animals in either the 10 
minute (F(1,18) = 0.018, p = 0.894; Figure 5.4C) or 3 hour probes (F(1,19) = 0.151, p = 
0.702; Figure 5.4D.  Hypoperfused mice did not differ from sham controls in the 
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Figure 5.4: Results of testing in the episodic memory task in the Morris  
water maze 
No difference was observed between sham and hypoperfused animals in the 
episodic memory task (A – E).  Hypoperfused animals performed as well as 
shams in the cued task (A) and in the number of trials taken to learn a 
platform location (B) and showed no impairment in probe tests (C, D) or 




5.3.4 Impaired working memory following chronic cerebral hypoperfusion 
 
In the first cohort tested on this task 7 hypoperfused animals were excluded from the 
analysis due to evidence of ischaemic neuronal damage, giving final group numbers 
for analysis of 10 sham and 3 hypoperfused animals. 
 
In the radial arm maze task hypoperfused mice showed a significantly higher rate of 
errors than sham operated controls (F(1,11) = 7.926; p = 0.017; Figure 5.5A).  There 
were significant differences between the groups in the number of errors made in 
training blocks 5 and 7 (p < 0.05 in each case).  Overall, both groups reduced the 
number of errors committed in each trial across the training period (F(7,77) = 8.935; p 
< 0.001).  There was no significant difference between the groups in the number of 
novel arm entries made within the first eight arm entries (F(1,11) = 0.930; p =0.356; 
Figure 5.5B).  Both groups improved the number of novel entries made in the initial 
eight arm entries over the training period (F(7,77) = 3.240; p = 0.005).  In the final 
training trials with a two minute delay after the fourth arm entry there was no 
difference between the groups in the number of errors committed (F(1,11) = 1.495; p 
=0.247).  Hypoperfused and sham animals also showed no difference in the number 
of novel arm entries made in the initial eight entries (F(1,11) = 1.088; p =0.319). 
 
In the second cohort of animals tested on this task 17 hypoperfused animals were 
excluded due to the presence of ischaemic neuronal damage.  This meant that the 




Hypoperfused mice in this cohort committed significantly more errors in the working 
memory task than shams (F(1,22) = 6.981; p = 0.015; Figure 5.5C).  Post hoc tests did 
not show differences between the groups on individual blocks.  There was a 
significant reduction in the number of errors committed across the training days by 
both groups (F(7,154) = 10.687; p < 0.001).  Hypoperfused mice also made 
significantly fewer novel arm entries in their first eight arm entries than shams (F(1,22) 
= 5.619; p = 0.027; Figure 5.5D).  A significant difference between the groups was 
observed in training block 7 (p < 0.05).  Both groups significantly increased the 
number of novel entries made in the first eight entries across the training days (F(7,154) 
= 9.223; p < 0.001).  In trials with an extra two minute delay there was no significant 
difference between hypoperfused and sham animals in the number of errors made 
(F(1,22) = 3.110; p = 0.092) or in the number of novel entries made in the first eight 





Figure 5.5: Working memory deficit in hypoperfused mice in the 8-arm  
radial maze task 
In the first cohort tested (A, B) hypoperfused mice made more working 
memory errors than sham operated controls in both the initial testing phase 
and that with a 2 minute delay (A).  There was no difference between the 
groups in the number of novel arm entries made in the first 8 arm entries until 
the extra delay was introduced (B).  In the second cohort tested 
hypoperfused mice made significantly more errors (C) and visited 
significantly fewer novel arms in the first 8 arm entries (D).  There was no 
difference between the groups on either measure when the extra delay was 







Evidence from studies of aging populations suggests a link between chronic cerebral 
hypoperfusion, white matter and cognition.  In humans a number of pathological 
states, such as atherosclerosis and diabetes are associated with hypoperfusion, 
making isolation of the effects of hypoperfusion alone on white matter and cognition 
difficult without the use of animal models.  The present study investigated the effects 
of chronic cerebral hypoperfusion on cognition and white matter pathology in wild-
type mice after one or two months of hypoperfusion.  The hypothesis that chronic 
cerebral hypoperfusion would cause damage to elements of white matter was upheld 
by the observation of diffuse changes to myelin, microglia and axons.  The 
hypothesised deficit in working memory in hypoperfused animals was observed 
while predicted deficits in spatial learning, memory and serial spatial learning were 
not. 
 
Diffuse loss of myelin integrity was observed at both one and two months after onset 
of chronic cerebral hypoperfusion and was accompanied by microglial activation and 
minimal damage to axons.  The observation of diffuse white matter damage and 
microglial activation in this study agrees with the findings of Shibata (2004).  These 
authors did not examine the cellular components of white matter and a novel finding 
of the study described here is the observation of axonal damage and alterations in 
specific myelin markers.  The behavioural results described in this study also agree 
with previous descriptions of behaviour in this model (Shibata et al., 2007), that is, 
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spatial working memory is impaired while spatial reference memory is intact.  The 
present study has the advantage that behavioural testing and pathological assessment 
were undertaken in the same animals, allowing direct extrapolation from the 
pathological to behavioural findings.  Additionally this study examined episodic 
memory, which has not previously been examined in this model and found that 
chronic hypoperfusion does not impact on this aspect of cognition. 
 
Cerebral hypoperfusion is associated with white matter damage and cognitive 
deficits in studies of aging humans (Breteler, 2000; Vernooij et al., 2008) as well as 
in rat models of reduced CBF (Farkas et al., 2007).  The underlying molecular 
mechanism resulting in damage to white matter following a period of cerebral 
hypoperfusion is unclear but the presence of white matter damage in the absence of a 
focal ischaemic lesion indicates that sustained sub-ischaemic levels of CBF reduction 
are capable of a pathological effect on the brain.  Shibata et al. (2004) report modest 
decreases in CBF of no more than 30% in the model used in this study and this 
should not be sufficient to cause tissue damage.  Clear disruption of cellular elements 
of white matter was observed in this study, with particular effects on myelin.  
Degradation of the myelin sheath can affect axon survival due to impairment of 
trophic support (Nave, 2010).  MAG was specifically shown to be affected by 
hypoperfusion in this study and is implicated in axo-glial interactions (Quarles, 
2009).  Disruption of MAG may affect axonal survival due to the role of MAG in 
expression and phosphorylation of elements of the axonal cytoskeleton (Dashiell et 
al., 2002).  Following myelin damage, microglial activation may further exacerbate 
disruptions in myelination through secretion of inflammatory cytokines (Schmitz and 
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Chew, 2008).  The present study does not explain how damage to white matter arises 
as a result of chronic cerebral hypoperfusion but it does demonstrate a clear 
relationship between chronic cerebral hypoperfusion, white matter damage and 
cognitive deficits. 
 
Spatial reference learning and memory were assessed in the Morris water maze after 
one month of hypoperfusion and hypoperfused animals showed no deficit in this 
task, consistent with the findings of Shibata et al. (2007).  Miki et al. (2008) reported 
a deficit in this task in their modified version of this model, however these authors 
also report hippocampal cell loss, which, given the importance of the hippocampus in 
learning this task (D'Hooge and De Deyn, 2001) is the most likely explanation of the 
deficits in this instance.  Similarly Nishio et al. (2010) found hippocampal atrophy in 
this model after 5 to 6 months of hypoperfusion which was associated with a spatial 
reference memory deficit.  Deficits in the spatial reference learning task can also be 
produced by lesions of connections to both the hippocampus (Nilsson et al., 1987) 
and other brain regions such as the thalamus (Savage et al., 1997), however the 
degree of damage observed in this model is not equivalent in severity to the type of 
lesion described in these studies and therefore may not be sufficient to produce a 
deficit by itself. 
 
The trials to criterion protocol has previously been used to examine “episodic-like 
memory” in transgenic models of Alzheimer’s disease (Chen et al., 2000; Daumas et 
al., 2008; Morris, 2001).  The number of trials taken for an animal’s performance to 
reach criterion on a given platform location is indicative of its ability to selectively 
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retrieve the information most relevant for swimming to this platform location and to 
ignore the information related to other platform locations and this acts as a measure 
of “episodic-like memory” (Chen et al., 2000).  Episodic memory deficits are 
relevant to the cognitive changes associated with white matter damage in humans 
(Bucur et al., 2008; Deary et al., 2003; Gold et al., 2010) but were not detectable in 
this model of hypoperfusion after two months of hypoperfusion.  The hippocampus is 
involved in episodic memory in rodents (Smith et al., 2006; Wood et al., 1999) but 
white matter involvement in episodic memory in rodents is not well investigated.  In 
humans, loss of white matter integrity in the medial temporal lobe is associated with 
deficits in episodic memory (Carmichael et al., In press; Charlton et al., 2010; 
Goldstein et al., 2009).  In this study it may have been the case that the training 
criterion used was not sufficiently stringent to expose subtle alterations in episodic 
memory function (Daumas et al., 2008). 
 
The presence of working memory deficits is another persistent theme in studies of 
white matter damage and cognitive deficits in humans (Appelman et al., 2010; 
Kennedy and Raz, 2009; O'Sullivan et al., 2001) and the radial arm maze task is a 
well established measure of working memory ability in rodents (Cole and Chappell-
Stephenson, 2003; Hyde et al., 1998; Olton and Samuelson, 1976).  This task has 
previously been used to demonstrate a deficit in working memory in this model of 
chronic cerebral hypoperfusion (Shibata et al., 2007), a finding which has been 
successfully replicated here.  This demonstrates that chronic cerebral hypoperfusion 
can, in isolation, produce sufficient damage to white matter to produce a cognitive 
impairment.  The specific attribution of cognitive deficits to chronic cerebral 
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hypoperfusion, regardless of its cause, has implications for how best to improve 
cognitive function and to measure improvements in individuals with chronic cerebral 
hypoperfusion, where there may be a range of coexisting pathologies.  In individuals 
with diabetes, for instance, there may be impairment in multiple cognitive domains 
(Kodl and Seaquist, 2008) but in addition to changes in white matter these 
individuals also show grey matter atrophy (Lobnig et al., 2006) which may affect 
different aspects of cognition to white matter damage.  This makes selection of the 
cognitive domain in which to assess the efficacy of interventions targeting white 
matter and chronic cerebral hypoperfusion related cognitive impairment important in 
order to avoid erroneously disregarding potentially useful interventions. 
 
Myelin pathology in this model was widespread in nature, with damage having been 
observed in the fimbria, internal capsule, optic tract, corpus callosum/external 
capsule and striatum.  This was true at both one and two months after the onset of 
hypoperfusion and no difference between the two time points in the level of damage 
present was observed (Coltman et al., In press).  This diffuse damage does not allow 
attribution of the cognitive deficit seen here to damage in a specific region, unlike 
some human investigations of cognitive impairments and white matter damage 
(Delano-Wood et al., 2009; Kennedy and Raz, 2009).  The hippocampus, 
parahippocampal region and prefrontal cortex are implicated in working memory in 
rodents (Hodges, 1996; Shaw et al., 1993).  In the case of the hippocampus, 
transection of its connections has been demonstrated to produce working memory 
deficits while leaving the grey matter structures intact (Aggleton et al., 1992; Wiig et 
al., 1995).  Given the number of brain regions involved in working memory tasks it 
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may be the case, in this model that disruption, rather than severance, of signalling 
between multiple brain regions is sufficient to produce a deficit in working memory.  
Other models of myelin loss have previously shown deficits in working memory in 
the Y maze (Xu et al., 2009) and T maze (Tanaka et al., 2009) and this has been 
linked with decreased conduction velocities and decreased axon diameters in the 
demyelinated fibres (Tanaka et al., 2009). 
 
Here, a model of chronic cerebral hypoperfusion, which produces selective damage 
to white matter, has been shown to display a deficit in working memory but not 
spatial reference memory, episodic like memory or memory flexibility.  This study 
has also been able to directly attribute the observed behavioural changes to white 
matter damage arising from chronic cerebral hypoperfusion and to identify the 
effects of chronic hypoperfusion on different components of white matter.  The 
working memory deficit demonstrated here may be attributable to a disruption of 
signalling between the numerous regions involved in working memory and is 








In general these studies indicated the vulnerability of white matter to brain injury and 
the importance of white matter injury in cognitive impairment which could also act 
as a link to Alzheimer’s disease (AD).  Initially, axonal pathology and an associated 
cognitive deficit were characterised in a model of mild traumatic brain injury (TBI).  
The effects of axonal damage on AD-related pathology were then examined by 
combining this TBI model with a transgenic model of AD.  Finally, selective myelin 
damage was found to be associated with an impairment in the specific cognitive 
domain of working memory in a model of chronic cerebral hypoperfusion. 
 
6.2 White matter pathology and cognitive outcomes in traumatic 
brain injury and hypoperfusion 
 
Both the mild TBI and hypoperfusion models used in this thesis demonstrate that 
selective damage to a specific element of white matter is sufficient to produce 
cognitive deficits.  The models are characterised by deficits in different cognitive 
domains and damage to different white matter components; impaired spatial 
reference learning was associated with axonal pathology in response to mild TBI and 
a spatial working memory deficit was linked to white matter damage, mainly of 
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myelin, in response to chronic cerebral hypoperfusion.  It is significant in both these 
models that the level of damage, whether to axons or myelin, is not equivalent in 
severity to the lesions of white matter tracts used in investigations of deficits 
produced by disconnection of different brain regions (e.g. Aggleton et al., 1992; 
Shaw et al., 1993; Wiig et al., 1995).  The anatomical patterns of damage observed in 
each model are very different, a potential basis for the differing cognitive deficits 
observed.  The mild TBI model demonstrates axonal pathology confined to specific, 
though changing regions over time; while the white matter pathology observed with 
chronic cerebral hypoperfusion is distributed diffusely.  This reflects the difference 
between the focal insult resulting from mild TBI and the global changes produced by 
chronic cerebral hypoperfusion.  In mild TBI disruption of projections from the 
thalamus, external capsule or cingulum could affect the coordination of input to the 
hippocampus or other regions required for spatial learning.  In chronic cerebral 
hypoperfusion diffuse loss of myelin integrity could affect conduction velocities in a 
number of tracts, also affecting harmonisation of inputs to regions needed for 
successful performance in a working memory task.  Although the specific 
mechanisms of cognitive dysfunction observed in the two models may differ, in both 
cases the observed damage may exert its behavioural effects by disrupting 
synchronous input to different regions necessary for cognitive function (Bartzokis, 
2004; Fields, 2008).  The presence of a loss of signal strength or decrease in 
conduction velocity could be determined by via electrophysiological measurement of 
extracellular field potentials and intracellular recordings of axonal conduction 
velocity (e.g. Ai et al., 2007; Teigler et al., 2009; Yamazaki et al., 2007). 
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One of the advantages of the present studies has been the ability to define which of 
the cellular components of white matter are affected by injury.  In human studies of 
cognitive changes and white matter damage resulting from TBI or cerebral 
hypoperfusion, identification of which elements of white matter are damaged is 
difficult using conventional imaging techniques.  Studies using diffusion tensor 
imaging (DTI) have the potential to address this issue by allowing separation of 
measures of myelin and axonal integrity by comparison of alterations in the diffusion 
pattern of water molecules.  An increase in diffusion of water molecules 
perpendicular to the white matter tract of interest is proposed to reflect reduced 
myelin integrity; while a decrease in diffusion parallel to the tract has been suggested 
to indicate compromised axonal integrity (Song et al., 2003).  The low spatial 
resolution of DTI compared to pathological investigation may result in ambiguity in 
the interpretation of imaging results but recent work from this group has 
demonstrated that DTI measurements correlate well with pathological assessment of 
myelin damage in the model of chronic cerebral hypoperfusion used in these studies 
(Holland et al., In press). 
 
The two models used in this thesis demonstrate that damage to either myelin or 
axons can have significant cognitive consequences and that the component injured, 
as well as the anatomical distribution of damage, may influence the type of deficit 
observed.  Typically, studies of patients who have suffered a mild TBI or those with 
white matter damage associated with cognitive deficits show impairments in a 
number of cognitive domains and the studies described here may indicate that 
multiple deficits reflect multiple pathologies in an individual.  Also assessment of 
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cerebral perfusion by single photon emission computed tomography (SPECT) 
imaging indicates that chronic regional hypoperfusion may exist in mild TBI patients 
who present with persistent cognitive impairment (Bonne, 2003), suggesting that 
there may be a role for both pathologies investigated here in persistent impairment 
after mild TBI.  It is not possible to rule out that mild TBI results in local 
hypoperfusion and subsequent damage to white matter in the model used in this 
thesis.  However, this may be unlikely given that hypoperfusion was shown to cause 
damage primarily to myelin, which was not damaged after mild TBI.  Establishment 
of regional perfusion levels in this model would determine its suitability for 
investigation of the respective contributions of brain trauma and subsequent 
hypoperfusion in mild TBI. 
 
As well as demonstrating different roles for different components of white matter in 
cognition the behavioural results presented in this thesis also have implications for 
cognition in disorders other than TBI and chronic hypoperfusion.  The white matter 
damage observed in AD (e.g. Brun and Englund, 1986; Englund et al., 1988) could 
contribute to the cognitive impairments characteristic of the disease.  Cognitive 
impairments also affects at least 40% of people with multiple sclerosis (Amato et al., 
2006), a primarily demyelinating disorder that also involves axonal damage.  Current 
treatment for AD focuses on cholinesterase inhibitors and blockade of NMDA 
receptors (Roberson and Mucke, 2006).  Cholinesterase inhibitors have also been 
adopted as treatments for cognitive impairment in multiple sclerosis (Porcel and 
Montalban, 2006) as well as mild TBI (Willer and Leddy, 2006) but their efficacy is 
limited and endures only as long as treatment is continued.  Addressing the white 
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matter pathology underlying the impairment in these disorders may offer a more 
permanent solution to cognitive impairment.  Axon degeneration may be targeted by 
calpain inhibitors, in an attempt to prevent breakdown of the neuronal cytoskeleton 
or blockade of the sodium–calcium exchanger in order to prevent a rise in 
intraaxonal calcium (Stys, 1998; Wang et al., 2004).  Reversal or prevention of 
myelin damage may rely on inhibition of inflammatory events or stimulation of 
remyelination by oligodendrocytes (Peru et al., 2008; Schmitz and Chew, 2008). 
 
6.3 White matter pathology and the development of Alzheimer’s 
disease 
 
The studies presented in this thesis demonstrate that cognitive dysfunction occurs in 
parallel with selective white matter damage.  Additionally the presence of axonal 
pathology following mild TBI may have implications for the development of another 
pathological condition, Alzheimer’s disease.  The presence of amyloid β (Aβ) 
accumulations at only 24 hours after injury demonstrates that early intervention may 
be important in ameliorating the effects of TBI on subsequent development of AD.  
Taken in conjunction with the progression of APP accumulations marking damaged 
axons observed following mild TBI the data suggests a mechanism by which Aβ 
accumulation may be distributed throughout the brain after injury.  The changing 
location of APP accumulations over time following injury may provide a spatially 
distributed pool of substrate for cleavage by β- and γ-secretases.  The temporal 
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progression of axonal damage, if mirrored by the progression of Aβ accumulation 
may also explain delayed onset of AD following TBI. 
 
Johnson et al. (2010) and Stokin et al. (2005) propose that accumulations of Aβ in 
axon bulbs result from cleavage of APP co-accumulated in axonal bulbs with β- and 
γ - secretase due to failure of axonal transport or to injury.  The axonal bulbs 
containing Aβ then lyse and expel Aβ into the parenchyma were it aggregates.  This 
does not provide an explanation for changes in Aβ levels in neuronal cell bodies in 
AD.  The continual development of axonal pathology after TBI in wild type mice 
implies a chronic pathological process such as Wallerian degeneration or retraction 
of the damaged axon rather than static levels of damage to axons.  Retraction of the 
damaged axon, along with proteins accumulated there towards the cell body (Saxena 
and Caroni, 2007) might elevate Aβ levels within the cell body but it is not possible 
to determine from the present studies whether this is the mechanism involved in 
axonal degeneration in this model.  Axonal retraction can be distinguished from 
Wallerian degeneration by the preservation of axonal material within the retracting 
axonal process rather than the axonal segmentation and subsequent phagocytosis 
characteristic of Wallerian degeneration (Saxena and Caroni, 2007).  Microtubule 
associated proteins might serve as useful markers to distinguish between these 
processes, with microtubule filaments remaining intact during axonal retraction and 
being disassembled in Wallerian degeneration.  The development of grey matter AD 
pathology may, alternatively, proceed independently of that in white matter.  
Intracellular increases in both Aβ and APP have been observed following TBI 
(Gentleman et al., 1993; Iwata et al., 2002), suggesting another pool of Aβ 
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production in grey matter.  In the AD model used here the presence of intracellular 
Aβ, even in the absence of injury, may make it difficult to detect subtle increases in 
background Aβ levels changes induced by TBI. 
 
Alterations in amyloidogenic processing of APP may also have implications for TBI, 
independent of their effects on AD risk.  Loane et al. (2009) have demonstrated 
preservation of cognitive function and attenuation of cell loss after TBI in β - 
secretase knockout mice and also with chronic partial inhibition of γ-secretase in 
wild-type mice.  These changes were observed in conjunction with either a reduction 
in or elimination of murine Aβ.  A therapeutically relevant study involving acute, 
short-term inhibition of β- or γ - secretase could indicate a potentially useful 
preventative measure for long-term axonal damage following TBI or development of 
AD.  Both intracellular and extracellular Aβ can disrupt axonal transport (Decker et 
al., 2010; Muresan and Muresan, 2009), potentially exacerbating axonal pathology 
observed after TBI and contributing to its persistence. 
 
Although not addressed here, modelling chronic cerebral hypoperfusion may also be 
useful in investigating AD.  Disease states that can result in hypoperfusion are risk 
factors for AD (Dickstein et al., 2010) and hypoperfusion is also a feature of AD 
(Johnson et al., 2005).  In a rat model of chronic cerebral hypoperfusion Aβ and β-
secretase levels have been shown to be elevated (Zhiyou et al., 2009).  Similarly, 
increases in Aβ have been observed in a transgenic mouse model of AD after chronic 
hypoperfusion, including in white matter (Kitaguchi et al., 2009).  Conversely, the 
deposition of Aβ in blood vessels, as observed in the brains of AD patients can cause 
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reduced perfusion by occlusion of capillaries (Thal et al., 2008).  Use of this 
technique for modelling hypoperfusion in transgenic mice would allow investigation 
of the role of hypoperfusion in AD development. 
 
6.4 Future studies 
 
The findings described in this thesis could be extended by further investigation of the 
mechanisms involved in the pathological and cognitive alterations observed.  
Identification of the effect of mild TBI or chronic cerebral hypoperfusion on firing 
synchronicity in neural networks necessary for cognition via electrophysiological 
techniques (e.g. Ai et al., 2007; Teigler et al., 2009; Yamazaki et al., 2007) would 
allow comparisons to be made between the effects of damage to particular 
components of white matter and lesions of entire white matter tracts.  This approach 
would also allow comparisons of the effects of myelin disruption and axonal damage 
on conduction velocity and signal strength. 
 
Determination of the secondary mechanisms causing progressive axonal pathology 
and the fate of damaged axons following mild TBI is also crucial for determining 
targets for modification of pathology following mild TBI.  Electron microscopy 
would allow observation of the effects of injury on the axonal cytoskeleton, allowing 
a distinction to be made between axonal degeneration and retraction following injury 
(Coleman, 2005).  In the chronic cerebral hypoperfusion model electron microscopy 
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could elucidate the effects of the observed disruption of specific myelin proteins on 
the integrity of the myelin sheath (e.g. Edgar et al., 2009). 
 
To further determine the relevance of mild TBI to the future development of AD, 
extension of studies of mild TBI in a transgenic model of AD is necessary.  This 
would demonstrate whether the pathology observed acutely after injury is associated 
with an accelerated progression of AD-related pathology in the model as well as 





The results described in this thesis demonstrate that relatively modest pathological 
alterations in white matter can have an extended impact on cognitive function as well 
as on development of another disease state.  The impact observed on cognition 
suggests that coordinated communication between different grey matter regions is as 
necessary for normal function as the integrity of the grey matter regions themselves.  
As well as being itself associated with persistent cognitive deficits, axonal pathology 
after mild TBI can also have features relevant in the context of AD soon after injury.  
This presents alleviation of axonal damage following TBI as a potential target for 
reducing subsequent risk of AD and repair or prevention of white matter damage as 
strategies for rescuing cognitive function in individuals who have experienced mild 
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Appendix A Additional behaviour and pathology results 




A.1: Axonal damage 4 hours after mild TBI 
Analysis of APP staining at 4 hours after mild TBI.  Injured animals showed 
significantly more axonal bulbs in the ipsilateral cingulum than controls. 





A.2: Myelin debris 4 hours after mild TBI 
Analysis of MAG staining 4 hours after mild TBI.  There were no differences 






A.3: Myelin integrity 4 hours after mild TBI 
Analysis of MBP staining at 4 hours after mild TBI.  There were no 
differences between the groups in relative optical density of MBP staining. 





A.4: Axonal damage 6 weeks after mild TBI 
Analysis of APP staining at 6 weeks after mild TBI.  Injured animals showed 
significantly more axonal bulbs in the ipsilateral external capsule and 






A.5: Myelin debris 6 weeks after mild TBI 
Analysis of MAG staining at 6 weeks after mild TBI.  There were no 






A.6: Myelin integrity 6 weeks after mild TBI 
Analysis of MBP staining at 6 weeks after mild TBI.  There were no 
differences between the groups in relative optical density of MBP staining. 





  4 hours 24 hours 72 hours 4 weeks 6 weeks 
  Sham Injured Sham Injured Sham Injured Sham Injured Sham Injured 
Haematoxilyn and eosin           
Cortex            
 Ipsilateral 2/4 4/5 3/4 4/5 2/3 1/4 0/5 1/5 0/7 0/10 
 Contralateral 0/4 0/5 1/4 0/5 0/3 0/4 0/5 0/5 0/7 0/10 
Hippocampus            
 Ipsilateral 1/4 1/5 1/4 0/5 1/3 0/4 0/5 0/5 0/7 3/10 
 Contralateral 0/4 0/5 1/4 0/5 0/3 0/4 0/5 0/5 0/7 0/10 
Thalamus            
 Ipsilateral 0/4 0/5 0/4 0/5 0/3 0/4 0/5 0/5 0/7 0/10 
 Contralateral 0/4 0/5 0/4 0/5 0/3 0/4 0/5 0/5 0/7 0/10 
            
Fluoro-jade C            
Cortex            
 Ipsilateral 1/4 0/5 4/4 3/5 2/3 2/4 1/5 2/5 0/7 1/10 
 Contralateral 0/4 0/5 0/4 0/5 0/3 1/4 0/5 0/5 0/7 0/10 
Hippocampus            
 Ipsilateral 0/4 0/5 0/4 0/5 0/3 0/4 0/5 0/5 0/7 0/10 
 Contralateral 0/4 0/5 0/4 0/5 0/3 0/4 0/5 0/5 0/7 0/10 
Thalamus            
 Ipsilateral 0/4 0/5 0/4 0/5 0/3 0/4 0/5 0/5 0/7 0/10 
 Contralateral 0/4 0/5 0/4 0/5 0/3 0/4 0/5 0/5 0/7 0/10 
 
A.7: Cell death following mild TBI using H&E and FJC staining 
Numbers of animals showing damaged neurons at each time point measured after injury using H&E and FJC staining.  Cell 
death was observed in regions close to the craniotomy site in both sham and injured animals and was most prominent in the 




Appendix B Additional pathology results following mild 






B.1: No significant accumulation of APP or Aβ in the contralateral 
external capsule and cingulum 24 hours after mild TBI
Accumulation of APP and Aβ in the contralateral external capsule and 
cingulum at 24 hours after injury was minimal and did not differ between 







B.2: Regions where APP and Aβ accumulations are unaffected by mild  
TBI 
APP and Aβ accumulations were unaltered 24 hours after mild FPI in the 
corpus callosum, cortex, internal capsule and thalamus bilaterally.  Line  





B.3: No effect of mild TBI on relative optical density of MBP staining at  
24 hours after injury 
There was no difference between injured and sham animals in density of 
MBP staining in any region examined 24 hours after mild FPI.  Values are 
expressed as relative optical density of the ipsilateral hemisphere normalised 






B.4: Intracellular Aβ is unaffected by mild TBI at 24 hours after injury 
Injured and sham animals showed the same levels of Aβ staining 
intracellularly in any regions examined at 24 hours after injury.  Line  





B.5: Intracellular levels of normal tau are unaffected at 24 hours after 
mild TBI 
Injured animals showed the same level of staining for normal tau in all 
regions examined as sham animals.  Line represents the mean value
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